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1 Introduction 
An unintended exposure to particulate form materials may occur during different stages 
of the production, use and recycling of particulate systems. They may enter the food 
chain, water and air, and thus have environmental consequences through their 
interactions with nutrients and environmental pollutants.1-10 It is known that ultrafine 
particles exhibit special properties that make them rather different from their 
corresponding bulk-scale equivalents. An increased specific surface area and quantum 
size effects are the main differentiating properties. However, the fate of ultra-fine 
particles in biological systems can be different from that of bulk material with the same 
composition. This work was performed to study the behavior of engineered particles 
under the conditions of biological environments. It is known that the specific surface 
area, solubility, hydrophobicity, surface functionalization, surface charge, colloidal 
stability, and particulate morphology may all influence the biological effects of 
nanomaterials. For that reason, questions concerning the mechanism of interaction on 
the cellular level are highly significant for this research. 
Within the framework of this thesis, two exemplary systems were addressed. As the 
model of a biologically active material, silver compounds and silver nanoparticles were 
investigated in particular. In contrast, barium sulfate was considered as a bioinert 
system. Extensive use of silver and barium sulfate in nanoparticulate forms in different 
applications was reported.1, 2, 4-6, 11-25 The morphological and colloidal characterization 
of particles has proven strong connections between properties such as average 
particle size, shape, and dispersity and inherently tuneable physico-chemical 
behavior.26-28 As previously reported, the biological responses to small particles differ 
from responses to larger particles of the same composition.27, 29 Considerable attention 
has been paid to investigations in complex media like physiological salt solutions and 
serum-rich environments, since particle interaction can depend on the presence of 
various components. This point is often underestimated when performing adequate 
control experiments. The interactions of silver compounds with biological media are 
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non-trivial cases, while catalytic reactions on the particle surface which depend on the 
size and shape of the nanoparticles can render the system very complicated.11, 20, 30-33  
This work comprises an attempt to correlate the synthesis procedures of toxicologically 
relevant particles and their behavior in complex biological media in terms of stability 
and dissolution with specific biological responses. 
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2 Theoretical background 
2.1 Definition and properties of colloidal systems 
The term colloid was introduced by Graham in 1861, from Greek meaning glue-like.34 
The word colloidal refers to a state of division, indicating that the molecules or 
polymolecular particles dispersed in a medium have a minimum dimension in one 
direction between of approximately 1 nm and 1 µm, or that discontinuities are found at 
distances of that magnitude in a system.35 Colloidal systems are combinations of two 
or more components. Another definition states that colloidal particles exist in a 
dispersed state and are intermediate in size between molecules and the smallest 
particles visible under an optical microscope. It is not essential for all three dimensions 
to be in the colloidal range. Colloidal dispersions are metastable mixtures. Although 
they are likely to form stable discrete phases upon storage, this can be a slow process. 
Gold sols prepared by Faraday in 1857 remain unchanged until today, i.e. more than 
150 years after their synthesis.36 
A colloidal system or dispersion contains particles of colloidal size, referred to as the 
dispersed substance, spread throughout a dispersing medium.36 Table 1 provides 
examples of systems constituting a colloidal domain. 
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Table 1: Examples of colloidal systems.36 
 
Dispersed substance Dispersing medium Common name Examples 
Liquid Gas Liquid aerosol Fog 
Solid Gas Solid aerosol Smoke 
Gas Liquid Foam Whipped cream 
Liquid Liquid Emulsion Mayonnaise 
Solid Liquid Sol Paint 
Gas Solid Solid foam Marshmallow 
Liquid Solid Solid emulsion Opal 
Solid Solid Solid sol Some alloys 
 
Colloidal systems often possess special physical and chemical properties. For 
instance, the electronic, optical, and chemical properties of the described systems may 
be varied by each component in the bulk form.  
In principle, there are two different approaches to the production of colloidal systems. 
The first method is called dispersion or the top-down approach. It is actually based on 
breaking down a system into its compositional sub-systems. Tools are used to cut, mill, 
and form materials into the desired shape and order. In this method, large particles of 
the substances are converted into particles of colloidal dimensions in the presence of 
a dispersion medium. Systems formed in this way are often highly unstable. To mitigate 
this effect, additional components are often used. 
The second principal way to produce colloids is condensation or aggregation. This 
tactic is the so-called bottom-up approach. It relies on material synthesis from atomic 
or molecular species via chemical reactions, allowing particles to grow in size. In this 
case, the original systems are sub-divisions of the emergent structure. This method 
consists of chemical reactions or changes of solvents whereby the atoms or molecules 
of the dispersed phase appear first, aggregating to form colloidal particles. To prevent 
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further growth, the conditions can be varied to permit the formation of sol particles. The 
control conditions are concentrations of the solutions, the presence of surfactants, and 
the temperature. Notably, the bottom-up approach uses the chemical properties of 
single molecules or atoms to cause self-organization into the desired formation. 
Due to their intrinsic physical and chemical properties, colloids are widely used in 
various fields of electronics, energy harvesting, water supply, geoscience and 
medicine.15, 37-43 
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2.2 Stability of colloids 
Since a colloidal system is defined as a combination of two or more components, a 
separation of these components may occur over time when they are exposed to the 
physical environment. The term of stability may rely on the physical state of the system: 
whether it is stable or dispersed. The forces that change this metastable state can be 
body forces as well as chemical transformation (e.g., surface oxidation). 
Unstable colloids tend to form aggregates or agglomerates. Upon reaction to external 
actions like stirring, mixing, milling, or sonication, such a formation can be reversible 
or irreversible. The irreversible form is often called coagulation.34, 44 
 
Figure 1: The interaction forces between pairs of colloidal particles.34 
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Using the DLVO theory (theory of Derjagin, Landau, Verwey and Overbeek), it is 
possible to describe the stability of colloidal disperse systems. Their stability comes 
from interactions between attractive and repulsive forces. Here, van der Waals forces 
play the role of attractive forces, and electrostatic forces act as repulsive forces. Figure 
1 describes the interaction of forces between pairs of colloidal particles. Provided that 
the net interaction energy is sufficiently repulsive, the particles cannot collide and stick 
together. The greater the repulsion, the more stable the system.34, 44  
In the presence of the Earth’s gravitation field, this additional force will act on particles 
in the colloidal state. The particles will have a tendency to sediment if the dispersing 
medium is less dense. The sedimentation velocity can be estimated using the equation 
of Stokes drag with gravitational force: 
𝑣𝑠 =  
2
9
Δ𝜌𝑔𝑎2
𝜂0
 
where vs is the sedimentation velocity, Δρ is the difference of densities, g is the 
gravitational constant, a is the particle radius, and η0 is the medium viscosity. It can be 
shown easily that the larger the particles, the greater the tendency to sediment. 
Colloidal particles will still sediment, even when attractive forces are small. Aggregates 
will sediment faster.34 
To prevent colloidal systems from altering, they can be enhanced by electrostatic or 
steric stabilization. Electrostatic stabilization of colloids is the mechanism used to 
counterbalance the van der Waals attraction with the repulsive Coulomb forces acting 
between the charged colloidal particles. The electric double layer plays a fundamental 
role in the electrostatic stabilization of sols. Particles can gain an electric charge when 
charged ions of the dispersion medium are adsorbed onto the particles surface. The 
electric double layer is the layer surrounding a particle of the dispersed phase, 
including the ions adsorbed on the particle surface and a layer of the counter-charged 
dispersion medium. Overall, it is electrically neutral. 
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Figure 2: Schematic representation of electric double layer. 
An electric double layer representation is shown in Figure 2. The Stern layer is created 
by counter ions (with opposite charge) attracted to the particle surface and closely 
attached by the electrostatic force. A diffuse layer can appear as a film of the dispersion 
medium next to the particle. The diffuse layer contains free ions with a higher 
concentration of counter ions. The ions of the diffuse layer are affected by the 
electrostatic force of the charged particle. The electrical potential within the electric 
double layer has its maximum on the particle surface (Stern layer).  
Depletion stabilization, another tactic of colloid stabilization, uses polymeric molecules 
added to the dispersion medium to prevent the aggregation of particles. The polymeric 
chains produce a repulsive force, counterbalancing the attractive van der Waals force 
acting on a particle approaching another particle. The two types of such stabilization 
are shown in Figure 3. 
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Figure 3: Schematic representation of depletion stabilization of colloids. 
Steric stabilization (upper particles in Figure 3) of colloids is achieved by polymer 
molecules attached to the particle surface forming a coating, which creates a repulsive 
force and separates the particles from others. Depletion stabilization (lower particles 
in Figure 3) of colloids involves unanchored (free) polymeric molecules creating 
repulsive forces between the approaching particles. The increased amount of polymer 
reduces the probability that two colloidal particles will touch.34, 44  
Electrosteric stabilization is a combination of the two mechanisms. At the same 
moment the electrostatic stabilization and the steric stability can be imparted by the 
polymer. Electrosteric stabilization is usually associated with the adsorption of 
polyelectrolytes onto the particle surface.45 
2.3 Toxicologically relevant particles 
Toxicology is a branch of biology, chemistry, and medicine concerned with the study 
of adverse effects of chemicals on living organisms. The main object of study is the 
damaging properties of chemical, biological and physical agents in biological systems. 
Nanotoxicology is a sub-division of particle toxicology. It addresses the toxicology of 
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ultrafine particles which appear to have harmful effects that are atypical for bulk 
material of the same composition. This field of study was established due to a large 
increase in nanoscale material production and use. It is known that ultrafine particles 
exhibit extraordinary properties that make them rather different from their 
corresponding bulk-scale equivalents. An increased specific surface area and quantum 
size effects are the main properties of interest. This results in different interactions with 
molecules (including biomolecules) at the surface of nanoparticles, which may lead to 
the ability to create materials with novel properties and applications.  
An unintended disposal of particulate materials may occur during different stages of 
production, use, and waste. They may enter the food chain, water and air, and thus 
have environmental consequences through their interactions with nutrients and 
environmental pollutants. For example, it has been shown that particulate air pollution 
in urban areas can be linked with acute increases in morbidity and mortality rates, 
especially for persons with obstructive lung and cardiovascular diseases.46-51 An early 
key study demonstrated that ultrafine TiO2 caused greater inflammation in rat lungs 
than exposure to the same airborne mass concentration of fine TiO2.28, 52 Dermal 
exposure to nanoparticulate systems in sunblock cream is already occurring and this 
trend is increasing.53, 54 Nanoparticles in food were reported to cross into the gut 
lymphatics and redistribute into other organs more readily than larger particles.55, 56 
2.3.1 Silver compounds 
Bacteria can adhere to and colonize the surfaces of various materials. Uncontrolled 
bacterial growth may result in the formation of bacterial biofilms which makes antibiotic 
treatment difficult if not ineffective.57, 58 In toxicology, silver is well known for its biocidal 
action. Herodot has already mentioned the antibacterial action of silver.59 Today, silver 
is still progressively implemented in many applications to move away from biocidal 
organic chemical agents towards inorganic additives. Silver can be used in much lower 
concentrations in a wider variety of products, including applications such as plastics, 
where high-temperature processing is not possible with organic compounds. Examples 
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of applications include: bacteriostatic water filters for household use; swimming pool 
algaecides; consumer commodities like mobile phones, refrigerators, and clothes; 
medical devices like catheters, implant surfaces, and plasters.1, 2, 4-6, 11-22 
Experimental investigations have shown that the biocidal action results from the 
interaction of silver ions with bacteria.11, 60, 61 To satisfy the diversity of application 
types, numerous different forms of silver compounds have been developed to serve 
the market. They can be primarily differentiated by the way the silver ions are stored 
in the product. Common silver products range from additives that store and release 
discrete silver ions from a ceramic or glass matrix, to products that contain silver ions 
as sparingly soluble silver salts (e.g., Ag2S, AgCl) or elemental silver (e.g., nanoscale 
silver metal).  
Humans can be exposed to silver nanoparticles through different ways. This can occur 
orally (e.g., by colloidal solutions), dermally (e.g., in contact with jewelry or burn 
creams), and via the inhalation of dusts or fumes. This is a major concern in handling 
silver nanoparticles at the point of production and during the manufacture of 
nanoparticle-containing materials. The interaction of silver compounds in biological 
media can be complex due to the reactions on the particle surface. Size and shape 
effects make the system even more complicated.11, 20, 30-33 
2.3.2 Barium sulfate 
Barium sulfate is an inorganic compound. It occurs as the mineral barite, which is the 
main commercial source of barium. Its white opaque appearance and high density 
leads to a wide range of possible applications such as oil drilling fluid, oil pigments 
("permanent white"), paper brightener, and plastic filler.23, 24 In medicine, barium sulfate 
is known as a radiocontrast agent; in the form of a suspension, it is frequently used for 
imaging of the digestive system and administrated orally.25 The low solubility of barium 
sulfate protects the patient from absorbing harmful amounts of the toxic metal. During 
production, shipping, handling, incorporation into final products, and the use and 
disposal of products containing barium sulfate, an unintended exposure to aerosolized 
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BaSO4 particles of different size and morphology may occur. Chronic exposure leads 
to baritosis in miners; nine cases of baritosis were described in a small factory in which 
barite was crushed, graded, and milled.9  
In biological investigations, it is often assumed that the behavior of barium sulfate is 
similar to other poorly soluble materials. Most studies have described the lung 
clearance of intratracheally instilled micron-sized radioactive BaSO4, and showed that 
the particle size influences the lung clearance of barite.8, 62 In general, biological 
responses to small particles differ from responses to larger particles of the same 
composition.27, 29 Moreover, the principal mechanisms of the lower toxicity and rapid 
lung clearance of BaSO4 particles are not fully understood.63 
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3 Materials and methods 
3.1 Dynamic light scattering 
Dynamic light scattering (DLS) is a method that can be used to determine the size 
distribution profile of particles in suspension or polymers in solution. In addition, it is 
possible to make a statement about the dispersity of a sample. In the dispersion 
medium, particles move randomly in accordance with the Brownian motion. Upon 
irradiation, light will be scattered by the colloidal particles. Depending on the position 
of the individual scatterer, constructive and destructive interference will occur. This 
leads to time-dependent fluctuations in the scattered light intensity, which can be 
measured by a detector. From the correlation of time and light intensity, an auto-
correlation function can be determined. By function analysis, the diffusion coefficient 
of the particles can be investigated. If temperature and solvent viscosity are known, 
the hydrodynamic diameter can be estimated. 
The hydrodynamic diameter and the zeta potential of the dispersed nanoparticles were 
measured by dynamic light scattering using a Malvern Zetasizer Nano ZS instrument. 
The polydispersity index (PDI) was below 0.3 in all cases, indicating a good degree of 
dispersion.44 
3.2 Nanoparticle tracking analysis 
Nanoparticle tracking analysis (NTA) is a method for visualizing and analyzing particles 
in liquids. This technique is based on the relationship of Brownian motion to particle 
size. Using a microscope, particles moving under Brownian motion can be detected. 
By image analysis, the average distance moved by each particle can be determined. 
This value allows the diffusion coefficient to be calculated. The hydrodynamic diameter 
of the aggregate can be estimated from the Stokes-Einstein equation:  
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𝐷𝑡 =  
𝑇𝑘𝐵
3𝜋𝜂𝑑
 
where Dt is the particle diffusion coefficient, T is the temperature, kB is the Boltzmann’s 
constant, η is the solvent viscosity, and d is the hydrodynamic diameter. 
NTA results in a size distribution profile of small particles with a diameter of 
approximately 10-1000 nm in liquid suspension. The examination was performed with 
a NanoSight LM10 HS instrument. 
3.3 Fluorescence spectroscopy 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy that analyzes 
fluorescence from a sample. This method is used for the qualitative and quantitative 
measurement of the fluorescence emission of substances after excitation with a light 
source. The typical wavelength of irradiation is between 200 and 1000 nm. A beam of 
light excites the electrons in molecules of specific compounds and causes them to emit 
light. At low concentrations, the fluorescence intensity will usually be proportional to 
the concentration of the fluorophore. Fluorescence spectroscopy was carried out with 
a Carry Eclipse fluorescence spectrophotometer. 
3.4 Atomic absorption spectroscopy 
Atomic absorption spectroscopy is used for the quantitative determination of individual 
elements. The method is based on the absorption of optical radiation by free atoms in 
the gaseous state. The test sample is converted to the gaseous state and atomized by 
means of thermal dissociation: by being sprayed into a flame while in its dissolved 
form. The atoms in the ground state then absorb optical radiation, which they will emit 
in the excited state. The light source is a hollow cathode lamp, which is made of the 
element to be determined. Standards with known analyte contents are required to 
establish the relationship between the measured absorbance and the component 
concentration. This relation relies on the Lambert-Beer law. 
Materials and methods 
 
 
22 
 
 
The concentration of silver was determined by atomic absorption spectroscopy 
(Thermo Electron Corporation, M-Series). The detection limit for silver was 1 μg L-1. 
Prior to analysis, silver nanoparticles were dissolved with nitric acid. Silver chloride 
was dissolved with ammonia solution. 
3.5 Energy-dispersive X-ray spectroscopy 
Energy-dispersive X-ray spectroscopy (EDX) is suitable for the qualitative and semi-
quantitative analysis of the elemental constituents of solids. This method is based on 
the interaction between some sources of X-ray excitation and a sample. Each element 
has a unique atomic structure, resulting in a unique set of peaks in its X-ray emission 
spectrum.64 The high-energy beam excites an electron in an inner shell, ejecting it from 
the shell. In this way, an electron hole is created. An electron from an outer (higher-
energy shell) then fills the hole. The energy difference between the higher-energy shell 
and the lower energy shell may be released as X-ray photon. Photon number and 
energy of the X-rays emitted from a specimen can be measured by an energy-
dispersive spectrometer. The energies of the X-rays are characteristic for the 
difference in energy between the two shells and the atomic structure of the emitting 
element. All elements with an atomic number >4 are detectable; the sensitivity 
increases with increasing atomic number.  
3.6 Thermogravimetric analysis 
Thermogravimetry (TG) is a thermal analysis method based on the measurement of a 
change in mass of a substance during a specific temperature program. The result can 
be plotted as mass change with temperature and time. TG can provide information 
about first-order phase transitions, including vaporization, sublimation, absorption, 
adsorption, and desorption. Similarly, TG can provide information about chemical 
processes like chemisorption, dehydration, decomposition, oxidation or reduction.65 
The profile of the mass loss usually contains characteristic regions, which can be 
associated with physical or chemical transformations.  
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The experiments were carried out in a dynamic oxygen atmosphere at a heating rate 
of 2 K min-1 in alumina crucibles. During thermogravimetric examination, the sample 
was heated up to 1273 K. The examination was performed with a TG 449 F3 Jupiter 
Netzsch instrument. 
3.7 X-ray powder diffraction 
X-ray diffraction is an analytical method for investigations of the atomic and molecular 
structure of a crystal. It is often used to identify unknown substances, to determine 
different polymorphic phases of the same material, and to ascertain the purity of a 
known substance. Crystals are regular arrays of atoms, and X-rays can be considered 
as waves of electromagnetic radiation. X-ray diffraction is based on the constructive 
interference of monochromatic X-rays and a crystalline sample. When the geometry of 
the incident X-rays impinging the sample satisfies Bragg’s law, constructive 
interference occurs and a peak in intensity occurs. Bragg’s law:  
𝑛 · 𝜆 = 2𝑑 · 𝑠𝑖𝑛𝜃 
where n is a positive integer, λ is the wavelength of incident wave, d is the spacing 
between diffracting planes, and θ is the incident angle. By measuring the angles and 
intensities of the diffracted beams, structural information can be obtained. The 
diffraction peak positions can be converted to d-spacings. This allows the identification 
of the mineral by comparing d-spacings with standard reference patterns. X-ray 
diffractometers consist of three basic elements: An X-ray tube, a sample holder, and 
an X-ray detector. X-rays are generated in a cathode ray tube by heating a filament to 
produce electrons, accelerating the electrons toward a target by applying a voltage, 
and bombarding the target material with electrons.  
X-ray powder diffraction was carried out on a Bruker D8 Advance instrument in Bragg-
Brentano mode with Cu K radiation (1.54 Å; 40 kV and 40 mA), using a silicon single 
crystal with a crystallographic (911) plane as a sample holder to minimize scattering. 
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For better homogenization, the dried powder samples were redispersed with ethanol 
on the silicon surface and then investigated in the range of 5 to 90 °2θ with a step size 
of 0.01 °2θ and a counting time of 0.6 s. Rietveld refinement (Le Bail method) with the 
program package TOPAS 4.2 from Bruker was performed to determine the average 
crystallite size and lattice parameters. For each Rietveld refinement, the instrumental 
correction determined with a standard powder sample LaB6 from NIST (National 
Institute of Standards and Technology) and standard reference material (SRM 660b; 
a(LaB6)=4.15689 Å) was taken into account. As a reference, a microcrystalline silver 
powder was also studied (Fluka, sintered for 3 h at 700 °C to ensure microcrystallinity 
and the absence of microstrain), mixed with LaB6. All powder diffraction data were 
obtained at ambient temperature, i.e. at 25±2 °C. 
The size of the crystallites was calculated with the Scherrer equation: 
𝐷 =
𝐾 ∙ 𝜆
𝐹𝑊𝐻𝑀 ∙ 𝑐𝑜𝑠𝜃
 
with K a constant set to 0.89, λ the wavelength of the X-ray radiation, FWHM the full 
width at half maximum for the diffraction peaks, and 𝜃 the diffraction angle. 
3.8 Scanning electron microscopy 
A scanning electron microscope (SEM) is a type of electron microscope that produces 
images of a sample by scanning it with a focused beam of electrons. SEM is usually 
used to depict structures if their dimensions are smaller than half the wavelength of 
visible light, and so they cannot be imaged with light microscopic techniques due to 
the Abbe diffraction limit. The electrons interact with atoms in the sample, producing 
various signals that can be detected and that contain information about the sample 
surface topography and composition. The secondary electron (SE) signal is the most 
often used signal. It varies with the topography of the sample surface: Edges are bright, 
recesses are dark. Backscattered electrons (BSE) consist of high-energy electrons that 
are back-scattered out of the specimen interaction volume by elastic scattering 
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interactions with sample atoms. BSE are often used to detect a contrast between areas 
with different chemical compositions, because heavy elements backscatter electrons 
more strongly than light elements.  
All scanning electron microscopic examinations were performed with ESEM Quanta 
400 FEG (FEI) instrument. All measurements were performed in high vacuum mode. 
If the specimen contained any volatile components such as water, they were put 
through a drying process before use in the high vacuum system. Because non-
conducting specimens will accumulate charge under electron bombardment, they were 
coated with a conducting layer (Au:Pd = 80:20). Typical thicknesses were in the range 
2-15 nm, depending on the sample and application. However, the cover layers should 
not be visible at the chosen magnification. A planar silicon wafer was used as a 
substrate. It was washed with acetone before the application. It was then mounted with 
carbon tape on an aluminum sample holder. 
3.9 Transmission electron microscopy 
Transmission electron microscopy (TEM) is a microscopic technique in which a beam 
of electrons is transmitted through an ultra-thin specimen, interacting with the 
specimen as it passes through. An image is formed from the interaction of the electrons 
transmitted through the specimen. There are four main components in a transmission 
electron microscope: An electron optical column, a vacuum system, the necessary 
electronics (lens supplies for focusing and deflecting the beam) and the high voltage 
generator for the electron source. The specimen must be thin enough to transmit the 
electrons. Passing through the specimen, transmitted electrons are collected and 
focused by the objective lens and a magnified real image of the specimen is projected 
by the projection lenses onto the viewing device at the bottom of the column.  
Transmission electron microscopy was carried out with a CM200 FEG-Instrument 
(Philips) with a Supertwin-Lens, operated at an accelerating voltage of 200 keV. The 
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samples were ultrasonically dispersed in ethanol and then transferred to holey carbon-
coated copper grids. 
Experimental section 
 
 
27 
 
 
4 Experimental section 
4.1 Synthesis of silver nanoparticles  
Poly(vinylpyrrolidone) (PVP)-coated silver nanoparticles were synthesized by 
reduction of silver ions with glucose (Figure 4) in the presence of PVP (Figure 5) in 
aqueous medium according to Wang et al.66  
 
Figure 4: Haworth projection of D-(+)-glucose. 
 
Figure 5: Structural formula of poly(vinylpyrrolidone). 
Here, 2 g glucose (11.10 mmol) and 1 g PVP (0.025 mmol based on the molar mass 
of the monomer; Mw = 40,000 g mol-1) were dissolved in 40 g water and heated to 90 °C 
in a silicon oil bath for 30 min. Then, 0.5 g AgNO3 (2.94 mmol) dissolved in 1 mL water 
was quickly added. Prior to addition, the silver nitrate solution was kept under light 
exclusion. The dispersion was kept at 90 °C for 1 h and then allowed to cool to room 
temperature. The synthesis was carried out under continuous vigorous stirring. During 
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the reaction, the color of the solution changed from transparent pale yellow to opaque 
grey. The particles were collected by ultracentrifugation (29,400 g; 20,000 rpm; 30 
min), redispersed in pure water and collected again by ultracentrifugation. In that way, 
NO3-, excess glucose and its oxidation products, excess polymer, and excess Ag+ were 
all removed. Then, the silver nanoparticles were redispersed in pure water by 
ultrasonication. In the last step, degassed and argon-saturated ultrapure water was 
used in order to avoid a release of silver ions from the particles during storage. All 
samples were stored at 4 °C in the dark until further analysis. The nanoparticles were 
characterized by scanning electron microscopy, energy-dispersive X-ray 
spectroscopy, dynamic light scattering, and nanoparticle tracking analysis. The final 
silver concentration in all dispersions was determined by atomic absorption 
spectroscopy.  
4.1.1 Synthesis of silver nanoparticles under partial air exposure and exposure 
to ambient light  
To study the influence of partial air exposure and exposure to ambient light, the 
synthesis according to Wang et al. was modified.66 For this, 16 g glucose (88.80 mmol) 
and 8 g PVP (0.2 mmol based on the molar mass of the monomer; Mw = 40,000 g mol- 1) 
were dissolved in 320 mL water and heated to 90 °C. Then 4 g AgNO3 (23.55 mmol) 
dissolved in 8 mL water was quickly added. Prior to the addition, the silver nitrate 
solution was kept under light exclusion. The dispersion was kept at 90 °C for different 
times (up to 7,000 min) and then allowed to cool to room temperature. For partial air 
exposure, a synthesis was performed in an Erlenmeyer flask covered with a concave 
watch glass. The system was heated to 90 °C in a silicon oil bath under ambient light 
exposure. The synthesis was carried out under continuous vigorous stirring. Aliquots 
of the reaction mixtures were taken after selected time periods. At each point, a 10 mL 
aliquot of the solution was taken with a syringe. The particles were collected and 
separated from synthesis by-products by ultracentrifugation (29,400 g; 20,000 rpm; 30 
min), redispersed in pure water and collected again by ultracentrifugation. This 
procedure was repeated three times. Thereby nitrate, excess glucose and its oxidation 
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products, excess PVP, and excess silver ions were removed. After the third cycle the 
sample was redispersed in 10 mL of distilled water. All samples were stored at 4 °C in 
the dark until further analysis. 
4.1.2 Synthesis of silver nanoparticles under exposure to ambient light  
To study the influence of exposure to ambient light, the synthesis according to Wang 
et al. was modified.66 For this, 16 g glucose (88.80 mmol) and 8 g (0.2 mmol based on 
the molar mass of the monomer; Mw = 40,000 g mol-1) PVP were dissolved in 320 mL 
water and heated to 90 °C. Then 4 g AgNO3 (23.55 mmol) dissolved in 8 mL water was 
quickly added. Prior to addition, the silver nitrate solution was kept under light 
exclusion. The dispersion was kept at 90 °C for different times (up to 7,000 min) and 
then allowed to cool to room temperature. The system was heated to 90 °C in a silicon 
oil bath under ambient light exposure. A synthesis was carried out in a round bottom 
flask with a reflux condenser (water cooling) under exposure to ambient light. All 
syntheses were carried out under continuous vigorous stirring. Aliquots of the reaction 
mixtures were taken after selected time periods. At each point, a 10 mL aliquot of the 
solution was taken with a syringe. The particles were collected and separated from the 
synthesis by-products by ultracentrifugation (29,400 g; 20,000 rpm; 30 min), 
redispersed in pure water and collected again by ultracentrifugation. This procedure 
was repeated three times. Thereby nitrate, excess glucose and its oxidation products, 
excess PVP, and excess silver ions were removed. After the third cycle, the sample 
was redispersed in 10 mL of distilled water. All samples were stored at 4 °C in the dark 
until further analysis. 
4.1.3 Synthesis of silver nanoparticles under light exclusion  
To study the influence of light exclusion, the synthesis according to Wang et al. was 
modified.66 Here, 16 g glucose (88.80 mmol) and 8 g PVP (0.2 mmol based on the 
molar mass of the monomer; Mw = 40,000 g mol-1) were dissolved in 320 mL water and 
heated to 90 °C. Then, 4 g AgNO3 (23.55 mmol) dissolved in 8 mL water was quickly 
added. Prior to addition, the silver nitrate solution was kept under light exclusion. The 
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dispersion was kept at 90 °C for different times (up to 7,000 min) and then allowed to 
cool to room temperature. The system was heated to 90 °C in a silicon oil bath under 
ambient light exposure. The synthesis was carried out in a round bottom flask with 
reflux condenser (water cooling). To determine the role of light exposure, the synthesis 
under reflux was also carried out under completely dark conditions, i.e. protected from 
irradiation during the whole reaction process. All syntheses were carried out under 
continuous vigorous stirring. Aliquots of the reaction mixtures were taken after selected 
time periods. At each point, a 10 mL aliquot of solution was taken with a syringe. The 
particles were collected and separated from by-products of synthesis by 
ultracentrifugation (29,400 g; 20,000 rpm; 30 min), redispersed in pure water and 
collected again by ultracentrifugation. This procedure was repeated three times. 
Thereby nitrate, excess glucose and its oxidation products, excess PVP, and excess 
silver ions were removed. After the third cycle, the sample was redispersed in 10 mL 
of distilled water. All samples were stored at 4 °C in the dark until further analysis. 
4.2 Synthesis of silver chloride nanoparticles 
4.2.1 Synthesis of PVP-coated silver chloride nanoparticles 
PVP-coated silver chloride nanoparticles were synthesized by precipitation from 
aqueous solutions of sodium chloride and silver nitrate in the presence of PVP.67 Here, 
45 mg sodium chloride (0.77 mmol) and 54 mg PVP (0.98 μmol based on the molar 
mass of the monomer; Mw = 55,000 g mol-1) were dissolved in 12 mL water and heated 
to 60 °C in a silicon oil bath under ambient light exposure for 30 min. Then, 57 mg 
AgNO3 (0.36 mmol) dissolved in 1 mL water was quickly added. Prior to addition, the 
silver nitrate solution was kept under light exclusion. The dispersion was stirred at 60 
°C for 30 min. The particles were collected by ultracentrifugation (28,600 g; 
13,000 rpm; 15 min), redispersed in pure water and collected again by 
ultracentrifugation. The silver chloride nanoparticles were then redispersed in water by 
ultrasonication. In that way, excess PVP and excess silver ions were removed. All 
samples were stored at 4 °C in the dark until further analysis. The nanoparticles were 
characterized by scanning electron microscopy, energy-dispersive X-ray 
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spectroscopy, dynamic light scattering, and nanoparticle tracking analysis. The final 
silver concentration in all dispersions was determined by atomic absorption 
spectroscopy.  
4.2.2 Synthesis of fluorescent silver chloride nanoparticles 
Poly(ethyleneimine) (PEI)-coated silver chloride nanoparticles were synthesized by 
precipitation from aqueous solutions of sodium chloride and silver nitrate in the 
presence of PEI by simultaneously pumping aqueous solutions of sodium chloride 
(30 mg mL-1; 0.51 mol L -1) and silver nitrate (25 mg mL-1; 0.15 mol L-1) in a volume 
ratio of 1 mL:1 mL into a stirred glass vessel containing 5 mL of PEI solution 
(2 mg mL- 1; 0.08 mmol L-1 based on the molar mass of the monomer; 
Mw = 25,000 g mol-1) for 1 min and then stirring for 10 min. Then, 50 µL of a solution of 
fluorescein in ethanol (20 mg mL-1; 0.06 mol L-1) was added as a dye. The dispersion 
was stirred at room temperature for 120 min. The particles were collected by 
ultracentrifugation (29,400 g; 20,000 rpm; 15 min), redispersed in pure water and 
collected again by ultracentrifugation. The excess PEI, dye and excess silver ions were 
removed. The silver chloride nanoparticles were then redispersed in water by 
ultrasonication. All samples were stored at 4 °C in the dark until further analysis. The 
nanoparticles were characterized by scanning electron microscopy, energy-dispersive 
X-ray spectroscopy, dynamic light scattering, and nanoparticle tracking analysis. The 
final silver concentration in all dispersions was determined by atomic absorption 
spectroscopy. Dye concentration was determined by UV/Vis spectroscopy. 
4.3 Synthesis of fluorescent barium sulfate particles 
4.3.1 Synthesis of fluorescent barium sulfate microparticles 
Fluorescent barium sulfate microparticles were synthesized by precipitation from 
aqueous solutions of barium hydroxide and sodium sulfate in the presence of 
carboxymethylcellulose conjugated with 6-aminofluorescein (CMC-F) by 
simultaneously pumping aqueous solutions of barium hydroxide (100 mmol L-1) and 
sodium sulfate (100 mmol L-1) in a volume ratio of 12 mL:12 mL into a stirred glass 
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vessel containing 25 mL of CMC-F solution (2 g L-1; 0.02 mmol L-1 based on the molar 
mass of the monomer; Mw = 90,000 g mol-1) for 0.5 min and then stirring for 10 min. 
The particles were collected and separated from synthesis by-products by 
ultracentrifugation (1,250 g; 3,000 rpm; 30 min), redispersed in pure water and 
collected again by ultracentrifugation. The barium sulfate microparticles were then 
redispersed in water by ultrasonication. All samples were stored at 4 °C in the dark 
until further analysis. The particles were characterized by scanning electron 
microscopy, energy-dispersive X-ray spectroscopy, dynamic light scattering, 
thermogravimetry, and X-ray powder diffraction.  
4.3.2 Synthesis of fluorescent barium sulfate sub-microparticles 
Fluorescent barium sulfate sub-microparticles were synthesized by precipitation from 
aqueous solutions of barium hydroxide and sodium sulfate in the presence of 
carboxymethylcellulose conjugated with 6-aminofluorescein by simultaneously 
pumping aqueous solutions of barium hydroxide (100 mmol L-1) and sodium sulfate 
(100 mmol L-1) via Y-connector in a volume ratio of 12 mL:12 mL into a stirred glass 
vessel containing 25 mL of CMC-F solution (2 g L-1; 0.02 mmol L-1 based on the molar 
mass of the monomer; Mw = 90,000 g mol-1) for 0.5 min and then stirring for 10 min. 
The particles were collected by centrifugation (1,250 g; 3,000 rpm; 30 min), 
redispersed in pure water and collected again by centrifugation. The barium sulfate 
sub-microparticles were then redispersed in water by ultrasonication. All samples were 
stored at 4 °C in the dark until further analysis. The particles were characterized by 
scanning electron microscopy, energy-dispersive X-ray spectroscopy, dynamic light 
scattering, thermogravimetry, and X-ray powder diffraction.  
4.3.3 Synthesis of fluorescent barium sulfate nanoparticles 
Fluorescent barium sulfate nanoparticles were synthesized by precipitation from 
solutions of barium chloride and sodium sulfate in the presence of 
carboxymethylcellulose conjugated with 6-aminofluorescein. Here, 1 mL of sodium 
sulfate solution (50 mmol L-1; ethanol:water = 1:1 v/v%) was pumped into a stirred 
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glass vessel containing 25 mL of barium chloride-CMC-F solution (50 mmol L-1 BaCl2; 
2 g L-1 CMC-F (0.02 mmol L-1 based on the molar mass of the monomer; 
Mw = 90,000 g mol-1)) for 4 min and stirred for 10 min. The particles were collected by 
ultracentrifugation (29,400 g; 20,000 rpm; 30 min), redispersed in pure water and 
collected again by ultracentrifugation. The barium sulfate nanoparticles were then 
redispersed in water by ultrasonication. All samples were stored at 4 °C in the dark 
until further analysis. The particles were characterized by scanning electron 
microscopy, energy-dispersive X-ray spectroscopy, dynamic light scattering, 
thermogravimetry and X-ray diffraction. 
4.4 Experiments with silver compounds in biological media 
4.4.1 Precipitation experiments with silver nitrate in biological media 
Silver nitrate was added to different biological media (physiological salt solution, 
glucose solution, phosphate-buffered saline, Lysogeny Broth, Roswell Park Memorial 
Institute medium) with silver ion concentrations between 0.01 g L-1 and 0.1 g L-1 (10 to 
100 ppm). This is the range for the cytotoxicity of silver.11, 31, 68-70 The solutions of silver 
nitrate were stirred at room temperature for 7 days under sterile conditions. Light was 
not explicitly excluded. All precipitates were isolated by ultracentrifugation (29,400 g; 
20,000 rpm; 30 min), redispersed in pure water, again subjected to ultracentrifugation 
and then analyzed by X-ray powder diffraction, scanning electron microscopy, and 
energy-dispersive X-ray spectroscopy. 
4.4.2 Immersion experiments with silver nanoparticles in biological media 
Silver nanoparticles were added to biological media (physiological salt solution, 
glucose solution, phosphate-buffered saline, Lysogeny Broth, Roswell Park Memorial 
Institute medium) with silver concentrations between 0.01 g L-1 and 0.1 g L-1 (10 to 100 
ppm). The particle synthesis was described in Chapter 4.1. The dispersions of silver 
nanoparticles in different media were stirred at room temperature for 7 days under 
sterile conditions. Light was not explicitly excluded. The nanoparticles and all 
precipitates were isolated by ultracentrifugation (29,400 g; 20,000; 30 min), 
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redispersed in pure water, again subjected to ultracentrifugation, and then analyzed by 
X-ray powder diffraction, scanning electron microscopy, and energy-dispersive X-ray 
spectroscopy. 
4.5  Quantification of dissolved species of silver compounds in 
biological media 
4.5.1 Determination of silver nanoparticle dissolution in DMEM supplemented 
with 10% FCS by atomic absorption spectroscopy  
Silver nanoparticles were added to Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal calf serum (FCS) with silver concentration 0.05 g L-1 
(50 ppm). The dispersions of silver nanoparticles in medium were incubated at 37 °C 
with gentle shaking for various periods of time under sterile conditions. After incubation, 
the samples were ultracentrifuged (77,000 g; 35,000 rpm; 30 min) and then the 
supernatant was pipetted off as much as possible, without removing any residue. Then, 
2 mL of supernatant was collected for analysis with 2 mL NH3 and 2 mL H2O. The 
residue was washed three times with ultrapure water by repeated ultracentrifugation 
(77,000 g; 35,000 rpm; 30 min). Then the residue was treated with 1 mL of 
concentrated HNO3 and 4 mL ultrapure water, shaken well and centrifuged (1,250 g; 
4,000 rpm; 60 min). The supernatant filled in the flask to 10 mL with ultrapure water. 
The new residue was treated with 1 mL of H2O and 2 mL NH3, also shaken well, and 
filled in the flask to 10 mL with ultrapure water. For all samples, duplicate procedures 
were performed and the values were averaged after analysis. From incubation until the 
last step, the samples were treated in their own thick-walled 10 mL centrifuge tubes to 
avoid losses. The silver concentration in all dispersions was determined by atomic 
absorption spectroscopy. A schematic representation of the protocol for quantification 
of silver nanoparticle dissolution is shown in Figure 6. 
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Figure 6: Schematic representation of the protocol for the quantification of silver 
nanoparticle dissolution. 
4.5.2 Determination of silver chloride nanoparticle dissolution in biological 
media 
Silver chloride nanoparticles were added to DMEM, DMEM medium supplemented 
with 10% FCS, 10% FCS solution and phosphate-buffered saline (PBS) with silver 
concentrations of 0.005 g L-1 and 0.1 g L-1 (5 ppm and 100 ppm). The dispersions of 
silver chloride nanoparticles in medium were incubated at 37 °C with gentle shaking 
for 24 h under sterile conditions. After incubation, the samples were ultracentrifuged 
(66,000 g; 30,000 rpm; 30 min) to separate dissolved silver species from remaining 
silver chloride nanoparticles. Then, 1 mL of supernatant was collected for analysis with 
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2 mL NH3 and 7 mL H2O. The silver concentration in all dispersions was determined 
by atomic absorption spectroscopy.  
4.5.3 Determination of silver nitrate solubility in biological media 
Silver nitrate solution was added to DMEM, DMEM medium supplemented with 10% 
FCS, 10% FCS solution and PBS with silver concentration 0.005 g L- 1 and 0.1 g L-1 
(5 ppm and 100 ppm). The dispersions of silver nitrate in biological medium were 
incubated at 37 °C with gentle shaking for 24 h under sterile conditions. After 
incubation, the samples were ultracentrifuged (66,000 g; 30,000 rpm; 30 min) to 
separate dissolved silver species. 1 mL of supernatant was collected for analysis with 
2 mL NH3 and 7 mL H2O. The silver concentration in all dispersions was determined 
by atomic absorption spectroscopy.  
4.6 Biological experiments 
4.6.1 Eukaryotic cell culture experiments  
4.6.1.1 Human mesenchymal stem cells 
Human mesenchymal stem cells (hMSCs, 3rd to 7th passage, Lonza, Walkersville Inc., 
MD, USA) were cultured in cell culture medium RPMI + 10% FCS using 24-well cell 
culture plates (Falcon, Becton Dickinson GmbH, Heidelberg, Germany). Cells were 
maintained at 37 °C in a humidified atmosphere with 5% CO2. hMSCs were sub-
cultivated every 7-14 days, depending on the cell proliferation rate. Adherent cells were 
washed with PBS solution (GIBCO, Life Technologies) and detached from the culture 
flasks by addition of 0.2 mL cm-2 0.25% trypsin/0.1% ethylenediamine tetraacetic acid 
(EDTA, Sigma-Aldrich, Taufkirchen, Germany) for 5 min at 37 °C. Then the hMSCs 
were collected and washed twice with RPMI + 10% FCS.  
Cell cultivation was performed by Jun.-Prof. Dr. Christina Sengstock. 
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4.6.1.2 Viability of hMSCs treated with silver chloride nanoparticles in 
correlation with fetal calf serum in medium  
For the viability experiment, 1.5·104 hMSCs mL-1 were cultured in RPMI 1640 
containing 10% FCS using a 24-well cell culture plate (Falcon, Becton Dickinson 
GmbH, Heidelberg, Germany) for 24 h. Afterwards, the hMSCs were cultured in cell 
culture medium RPMI 1640 with or without 10% FCS, in the presence or absence of 
5.0, 2.5, 2.0, 1.0, and 0.5 μg mL-1 silver chloride nanoparticles for 24 h under cell 
culture conditions. The working solutions were prepared by serial dilutions of a PVP-
coated AgCl nanoparticle stock solution with sterile ultrapure water. The viability and 
morphology of the incubated hMSCs were analyzed using calcein-acetoxymethylester 
(calcein-AM, Calbiochem, Schwalbach, Germany) fluorescence staining. After 
incubation for 24 h, the nanoparticle-treated and silver ion-treated cells were washed 
twice with RPMI and incubated with calcein-AM (1 mM) at 37 °C for 30 min under cell 
culture conditions. Then, the adherent cells were washed again with RPMI and 
analyzed by fluorescence microscopy (Olympus MVX10, Olympus, Hamburg, 
Germany). Fluorescence microphotographs were taken (Cell P, Olympus) and digitally 
processed using Adobe Photoshop® 7.0. The cell morphology was analyzed by phase 
contrast microscopy (Olympus CK 2) and documented by microphotography (Camedia 
C3030, Olympus). In this method, living cells emit green fluorescence. 
Cell cultivation and viability assay were performed by Jun.-Prof. Dr. Christina 
Sengstock. 
4.6.1.3 Peripheral blood mononuclear cells 
Peripheral blood mononuclear cells (PBMC) were isolated by a single-step procedure 
that was based on a discontinuous double-Ficoll gradient described by English and 
Andersen.71 Briefly, EDTA-anticoagulated peripheral blood (9 mL, Monovette®, 
Sarstedt, Nürnbrecht, Germany), obtained from healthy volunteers (covered by the 
approval of the local ethics committee), was diluted with an equal volume of 0.9% 
aqueous NaCl and carefully overlaid on a double gradient formed by layering 10 mL of 
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aqueous polysucrose/sodium diatrizoate, adjusted to a density of 1.077 g mL-1 
(Histopaque 1077, Sigma-Aldrich, Taufkirchen, Germany), on 10 mL Histopaque 1119 
(Sigma-Aldrich) in 50 mL Falcon tubes (BD-Biosciences, Heidelberg, Germany). The 
tubes were centrifuged at 700 g for 30 min at room temperature. After centrifugation, 
two distinct leukocyte cell layers (PBMC and polymorphonuclear neutrophil 
granulocytes (PMN)) were obtained above the bottom sediment of erythrocytes. The 
PBMC layer was carefully aspirated and transferred to a separate 50 mL tube, and the 
tube was filled with PBS (Sigma-Aldrich) and centrifuged at 200 g for 15 min at 4 °C. 
This method led to more than 95% pure and viable PBMC. Cell counting was 
performed using Tuerk staining solution (Sigma-Aldrich). The isolated cells were 
adjusted to 1∙106 cells mL-1 in RPMI 1640 (GIBCO, Invitrogen GmbH, Karlsruhe, 
Germany), cell culture medium supplemented with L-glutamine (0.3 g L-1), sodium 
bicarbonate (2.0 g L-1), 10% FCS (GIBCO, Invitrogen GmbH), and 20 mM 
N- (2- hydroxyethyl)-piperazine-N´-(2-ethanesulfonic acid) (HEPES, Sigma-Aldrich). 
For the differentiation of monocytes and T-cells in the PBMC-fraction, the cells were 
centrifuged at 370 g for 5 min at room temperature. The supernatants were discarded, 
and the pellets were carefully resuspended. Fluorochrome-labelled anti-CD3 and anti-
CD14 (BD Bioscience, Heidelberg, Germany) were added (20 µL each), and the 
samples were incubated for 30 min in the dark at room temperature. Then the cells 
were washed with PBS, centrifuged at 370 g for 5 min at room temperature, and fixed 
with 1.5% formaldehyde. 
Cell cultivation and viability assay were performed by Jun.-Prof. Dr. Christina 
Sengstock. 
4.6.1.4 Uptake of silver chloride nanoparticles by HeLa cells 
HeLa cells were cultivated in DMEM, supplemented with 10% FCS at 37 °C in a 
humidified atmosphere with 5% CO2. Approximately 12 h prior to the addition of the 
silver compounds, the cells were seeded into a six-well plate over cover glass. The 
silver concentration in cell culture medium was 2 µg mL-1 (2 ppm). The cells were 
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incubated for 4 h under cell culture conditions, then washed three times with PBS, and 
studied under a fluorescence microscope BZ-9000 (Keyence, Japan).  
Cell cultivation and uptake experiments were performed by Dr. Svitlana Chernousova. 
4.6.1.5 NR8383 cells 
Rat alveolar macrophages NR8383 were purchased from ATCC via LGC Standards 
GmbH (Wesel, Germany) and cultivated at 37 °C, 100% humidity and 5% CO2 in Ham’s 
F12 + 15% FCS (Biochrom KG, Berlin, Germany), 2 mM L-glutamine, 100 µg mL-1 
penicillin, and 100 µg mL-1 streptomycin. Approximately 1.2∙106 cells were seeded in 
2.5 mL medium each. 
4.6.1.5.1 Determination of cellular BaSO4 particle uptake by laser scanning 
microscopy 
Laser scanning microscopy was performed to demonstrate the occurrence of 
intracellular BaSO4 particles in NR8383 cells after incubation. Therefore, NR8383 cells 
were subconfluently grown on 2-well Lab-TekTM glass chamber slides (Thermo Fisher 
Scientific, Langenselbold, Germany) and subsequently washed and exposed to 
50 µg mL-1 BaSO4 particles for 24 h under cell culture conditions. After this incubation, 
cells were labeled with specific cell organelle fluorescent probes (Life Technologies). 
As a marker for late endosomes and lysosomes, the cells were incubated with 50 nM 
Lyso Tracker Red DND 99 in pure RPMI 1640 for 30 min at 37 °C. For labelling of the 
cell nucleus, the cells were incubated with 162 µM Hoechst33342 in pure RPMI 1640 
for 5 min at 37 °C. After three rinses in RPMI 1640, the cells were mounted on glass 
chamber slides. Images were taken using a 40x oil immersion objective in a laser 
scanning microscope (LSM 700; Zeiss) and Zeiss 2010 software. 
Laser scanning microscopy studies were performed by Dr. Isabell Schremmer and 
Jun.- Prof. Dr. Christina Sengstock. 
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4.6.1.5.2 Particle-induced cell migration assay 
Prior to the test, the trans-retinal differentiated human leukemia cells (dHL-60) were 
starved by culturing without FCS overnight. For this, 200,000 of these dHL-60 cells 
were added to 200 µL RPMI without FCS and seeded in each plate well insert 
(THINCERT, 3 µm pore size, Greiner bio-one, Frickenhausen, Germany) of the 
"Boyden Chamber". The inserts were placed on 24 black well plates (Krystal, Duna 
Labortechnik, Asbach, Germany). The wells contained 500 µL supernatants of the 
challenged NR8383 cells. The dHL-60 cells were allowed to migrate across the 
membrane at 37 °C, 100% humidity and 5% CO2 for 20 h. Four plate wells were left 
without inserts and served for calibration. For this purpose, up to 200,000 dHL-60 cells 
were seeded directly into the plate wells.  
The migrated cells were stained by adding 500 µL calcein-AM (>90% HPLC, Sigma-
Aldrich) (4 µM in PBS) into the plate wells. Calcein-AM was delivered as 4 mM solution 
in DMSO. The solution was stored in aliquots at -18 °C. Prior to use, 12.5 µL of this 
solution was diluted in 12.5 mL PBS to yield a final concentration of 4 µM. The samples 
were incubated for another 60 min at 37 °C and 5% CO2. Following staining, the cell 
suspensions were removed from the plate wells and collected by centrifugation at 
400 g for 5 min at room temperature. Here, 850 µL of the supernatant was discarded 
and the pellet was resuspended in the remaining 150 µL. In parallel, adherent cells 
were detached from the outside of the inserts by incubating the inserts in the plate 
wells with 500 µL trypsin/EDTA (0.05%/0.02%, Biochrom KG, Berlin, Germany). 
Incubation was performed for 10 min at 37 °C and 5% CO2 and the inserts were 
removed from the plate wells. Finally, the 150 µL samples of the collected cells were 
added to the detached cells in the plate wells. Fluorescence was measured at 490/520 
nm (SpectraMax M3, Molecular Devices, Sunnyvale, USA). Before each 
measurement, the plates were vigorously shaken by the shaker which is integrated in 
the fluorescent photometer. 
Particle induced cell migration assay was performed by Dr. Isabell Schremmer. 
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4.6.2 Bacterial culture experiments 
4.6.2.1 Staphylococcus aureus 
Bacterial tests were performed with Staphylococcus aureus (DSMZ 1104), obtained 
from the DSMZ (German Collection of Microorganisms and Cell Cultures). S. aureus 
was grown in BHI broth (brain-heart infusion broth, bioMérieux, Nürtingen, Germany) 
overnight at 37 °C in a water bath. Bacterial concentrations of overnight cultures were 
measured using a Densichek® (bioMérieux, Lyon, France) turbidity photometer. The 
calculation of bacterial counts was based on turbidity standard solutions (McFarland 
scale). The antimicrobial activity of nanoparticulate silver chloride was tested using 
standard methods which determine the minimum inhibitory concentration (MIC) and 
the minimum bactericidal concentration (MBC). MIC was determined in RPMI 1640 
(Life Technologies) containing 10% FCS (Life Technologies) and L-glutamine 
(0.3 g L- 1, Life Technologies), and defined as the lowest silver concentration able to 
inhibit bacterial growth (no visible growth) in 2 mL plastic macrodilution test tubes. 
Therefore, working silver stock solutions (50 µL) were added to 1 mL of the respective 
liquid culture medium, and different cell numbers (103 to 106 mL-1) of bacteria were 
used for inoculation. Cells were incubated in a cell culture incubator (RPMI + 10% FCS) 
in the presence of 5% carbon dioxide in a humidified atmosphere at 37 °C overnight. 
The minimum bactericidal concentration (MBC) was subsequently determined by 
plating 100 µL aliquots of the MIC samples on blood agar plates. The MBC was defined 
as the lowest silver concentration which completely prevented colony forming units 
(CFU) on the agar plate. 
Antimicrobial tests were performed by Jun.-Prof. Dr. Christina Sengstock. 
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5 Results and discussions 
5.1 Characterization of silver nanoparticles 
Silver nanoparticles were synthesized with glucose in the presence of 
poly(vinylpyrrolidone) according to Wang et al.66 Particles were characterized using 
scanning electron microscopy and dynamic light scattering. All measurements were 
performed with the purified nanoparticles. The size analysis by dynamic light scattering 
is shown in Figure 7. The measurement was carried out in a disposable polystyrene 
cuvette of dilute aqueous dispersion. 
 
Figure 7: Particle size distribution of PVP-coated silver nanoparticles as measured by 
dynamic light scattering. 
The hydrodynamic diameter as measured by dynamic light scattering pattern was 
about 120 nm. The hydrodynamic diameter gives information about the metal core and 
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outer ligand shell, which may consist of adsorbed PVP in our case. The polydispersity 
index (PDI) was lower than 0.3 in all cases. It is typical for a well-dispersed system.  
The zeta potential distribution is shown in Figure 8. The particles were negatively 
charged with the zeta potential of -20 mV. This means that PVP-coated silver 
nanoparticles were electrosterically stabilized, because PVP molecules provide 
colloidal stability of particles by steric repulsion. 
 
Figure 8: Zeta potential of PVP-coated silver nanoparticles. 
Figure 9 shows a typical SEM image of the synthesized silver nanoparticles. For 
preparation, the diluted dispersion of purified silver nanoparticles was dried on a silicon 
wafer. Figure 9 depicts particles with prevalent spherical morphology with a minor 
presence of polygones. The particles were well distributed on the substrate and show 
no strong agglomeration. The particle size distribution was performed by electron 
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microscopy and is displayed in Figure 10. The diameter of the metallic core was about 
65 nm. 
  
Figure 9: Scanning electron microscopy images of PVP-coated silver nanoparticles. 
 
Figure 10: Particle size distribution of PVP-coated silver nanoparticles as measured 
by scanning electron microscopy. 
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Energy-dispersive X-ray spectroscopy confirmed the formation of silver nanoparticles 
(Figure 11). The dominant peak of silicon resulted from the substrate (silicon wafer). 
The carbon peak was due to the PVP polymer. 
 
Figure 11: Energy-dispersive X-ray spectrum of PVP-coated silver nanoparticles. 
In summary, the hydrodynamic diameter of PVP-coated silver nanoparticles was about 
100 nm. The core diameter of synthesized particles was around 65 nm. Dynamic light 
scattering and scanning electron microscopy each probe different particle sizes. This 
can be explained by investigation of the same sample in non-comparable states. 
Electron microscopy gives information about the dried sample, while dynamic light 
scattering measurements were performed in dispersion. Another possible explanation 
is an overestimation of the scattered light proportion of larger particles and possible 
agglomerates. 
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In particular, PVP-coated silver nanoparticles were explicitly used for characterization 
of the physico-chemical properties (growth, dissolution, protein adsorption, 
dispersability) and the cellular consequences of exposure to a broad range of biological 
test systems.31, 68, 69, 72-75 Moreover, in the described synthetic pathway, particles can 
be produced with high quality and in large quantities. This point is essential for 
biological experiments, because reliably-produced particles are required for a large 
number of experiments.72 
Synthesized PVP-coated silver nanoparticles were used in this study for immersion 
experiments, evaluation of dissolution in cell culture media as well as for biological 
investigations.
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5.2 Characterization of PVP-coated silver nanoparticles synthesized 
under the variation of light and air exposure  
As described in the previous chapter, the synthesis of silver nanoparticles in the 
presence of poly(vinylpyrrolidone) (PVP) by reduction of silver ions with glucose offers 
a reliable quality and quantity of material for further investigations.72 However, the 
presence of a small fraction of non-spherical particles (triangular plates) was observed. 
Morphological and colloidal characterization of silver nanoparticles demonstrates 
strong correlations between average particle size, shape, and dispersity and the 
observed tunable physico-chemical behavior of those particles.76, 77 
The structure of silver nanoparticles was studied during the reduction of silver ions with 
glucose under the variety of light and air exposures. PVP was used as a capping agent. 
The structural and morphological properties of silver nanoparticles were studied 
extensively by electron microscopy and X-ray powder diffraction. For all kinds of 
measurements, only purified dispersions of silver nanoparticles were used. The 
washing step was consisted of ultracentrifugation and eventual sonication in pure 
water. After that, all of the samples were preserved in light exclusion conditions at 4 °C. 
The detailed procedure of synthesis was described in Chapter 4.1. Variations of in air 
(oxygen) and light exposure were selected to be studied, while the possible effects on 
silver particle formation were shown.78 
As shown by scanning electron microscopy, the diameter of the nanoparticles 
increased monotonically during the synthesis. The particle size from SEM was 
obtained by image analysis to differentiate between particles of various morphology. 
Figure 12 shows the growth of the spherical silver nanoparticles during the synthesis. 
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Figure 12: Growth of spherical silver nanoparticles over time as determined by 
scanning electron microscopy. Open circles: Synthesis in air; crossed circles: 
Synthesis under reflux and ambient light exposure; closed circles: Synthesis under 
reflux in the dark. 
For the estimation of particle size, at least 200 individual spherical particles were 
analyzed. It is notable that the particles grew rapidly in diameter during the first 500 min 
and then remain at a practically constant size. There is no significant difference 
between the syntheses under variation of light or air exposure, although the deviation 
in particle diameters increases with extended reaction time. Figure 13 displays the 
particle size distribution of the spherical nanoparticles for different reaction times. In 
spite of the fact that the particle size distribution became broader with longer reaction 
times, the nucleation took place mainly at the beginning of the synthesis and was not 
continuous. 
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Figure 13: Particle size distribution of the spherical nanoparticles (as diameter) as a 
function of reaction time (N≥200). 
Figure 14 shows representative scanning electron micrographs of silver nanoparticle 
samples after different time periods. The dispersions were dried in air, and a silicon 
wafer was used as a substrate. The diameter of the spherical particles increased with 
time. A closer look at the data indicated that triangular particles occurred first as a small 
fraction of the particle population but then strongly increased in number and also in 
size. 
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Figure 14: Representative SEM images of silver nanoparticles synthesized under 
reflux and ambient light exposure after 30 min (A), 100 min (B), 210 min (C), 450 min 
(D), 1210 min (E) and 3250 min (F). 
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Figure 14: Fraction of triangles on all silver nanoparticles. Open triangles: Synthesis 
under reflux and ambient light exposure; closed triangles: Synthesis under reflux in the 
dark.  
The fraction of triangles was computed by analyzing the number of particles (N>2,000). 
The increase in the fraction of triangles over the reaction time is shown in Figure 14. 
Furthermore, a very small fraction of silver triangles in the overall particle population 
could be observed even in the early stages of synthesis. The fraction of triangles 
increased rapidly during the first 500 min. After 3500 min, around 13% of particles were 
triangles. The presence or absence of light had no significant effect on the particle 
shape.  
Scanning electron images show geometrically well-defined flat silver triangles. The 
triangle edge length also increased monotonically during the synthesis (Figure 15) to 
about 140 nm after 1000 min. At the same time, the spherical particles reached a 
diameter of only 65 nm. Similarly, light exposure was insignificant. However, spheres 
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and triangles originated from separate nucleation steps with different nucleation and 
growth kinetics. The thickness of the particles could neither be determined by SEM 
(because it was too small) nor by TEM (because it was impossible to orient the flat 
triangles perpendicular to the electron beam). In a similar study, Zhang et al. 
determined the thickness of silver nanoplates by atomic force microscopy (AFM) to be 
below 10 nm, which appeared to be realistic in our case as well.79 
 
Figure 15: Particle size for different morphologies vs. time: spheres (maximum 
diameter) and triangles (edge length of a perfect triangle): Open circles: Spherical 
particles from the synthesis under reflux and ambient light exposure; open triangles: 
Triangular particles from the synthesis under reflux and ambient light exposure; closed 
circles: Spherical particles from the synthesis under reflux in the dark; closed triangles: 
Triangular particles from the synthesis under reflux in the dark.  
The crystallographic properties of the nanoparticles were analyzed by X-ray powder 
diffraction. For an accurate determination of the unit cell parameter a of silver, a 
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nanoparticle sample was mixed with the LaB6 standard before the diffraction 
experiment. LaB6 is certified with respect to its lattice parameter and internal stress. 
Figure 16 shows a representative X-ray powder diffractogram with narrow peaks from 
LaB6 and broad peaks from nanocrystalline silver. It was possible to determine the 
silver crystallite size to 24 nm and the silver unit cell parameter a with 4.0877(2) Å. 
 
 
Figure 16: Representative X-ray powder diffractogram (with Rietveld refinement, 
Rwp = 6.6) of a mixture of silver nanoparticles with the microcrystalline standard LaB6. 
Notably, in comparison with the narrow peaks of the LaB6 standard, the peak width for 
the silver nanoparticles was considerably increased. The silver peaks are denoted by 
their lattice plane indices. 
Figure 17 shows the unit cell parameter a of silver nanoparticles as a function of 
diameter. This was determined without the LaB6 standard, therefore, the standard 
deviations were higher for the individual data points due to uncertainties of the 
measurement, e.g., the sample displacement error.80 Microcrystalline silver powder 
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was generated by sintering commercially available silver powder for 3 h at 700 °C to 
ensure microcrystallinity and the absence of a microstrain. For microcrystalline silver 
mixed with LaB6, a=4.08635 Å was found, in good agreement with literature data 
(4.0862 Å81 and 4.086 Å82). The lattice of the nanoparticles was significantly expanded 
in comparison to microcrystalline silver, but there is no significant variation in the unit 
cell parameter of nanoparticles as a function of their size, and also no influence of air 
or light exposure. Fukuhara et al. confirmed the lattice expansion of a unit cell in three 
kinds of nanoscale compound particles like MgO, α-Fe2O3 and TiC.83 
 
Figure 17: Unit cell parameter a vs. particle size as determined by dynamic light 
scattering including error bars. Open circles: Synthesis in air under ambient light 
exposure; crossed circles: Synthesis under reflux and ambient light exposure; closed 
circles: Synthesis under reflux in the dark. The circled value at 60 nm corresponds to 
a sample measured with the internal standard LaB6. The dashed line corresponds to 
microcrystalline silver, measured with the internal standard LaB6. 
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Rietveld analysis gave the crystallite size of the nanoparticles from X-ray diffraction 
peak broadening (Figure 16). The nanoparticle displayed a linear correlation 
(y=0.25x+3.5; R2=0.86) between particle size and crystallite size. The Rietveld data 
were in excellent agreement with TEM data on the domain size (see below). This 
indicated that under these reducing conditions, the nucleation led to multiply twinned 
nanoparticles with domains that were of course smaller than the particle diameter. 
During the silver nanoparticle growth, the domains grew as well, but the domain 
structure of the nanoparticles remained unchanged. Otherwise, it would not be 
possible to observe a linear correlation between domain size and particle diameter. If 
secondary nucleation occurred, the domain size would increase more slowly than the 
particle diameter. Notably, there was again no effect of air or light exposure. 
The Rietveld analysis averages out many particles without being able to differentiate 
between individual particles of different size and shape. However, as the spheres 
constituted the majority of the particle population and as they were rather uniform in 
size, it could be safely assumed that X-ray powder diffraction gave a reasonable 
approximation of the domain size of spherical particles. 
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Figure 18: Crystallite size from X-ray powder diffraction vs. particle size from dynamic 
light scattering. Open circles: Synthesis in air under ambient light exposure; crossed 
circles: Synthesis under reflux and ambient light exposure; closed circles: Synthesis 
under reflux in the dark. The four open pentagons denote domain sizes as derived from 
TEM data (see Figure 19 A-D). 
Further evidence came from transmission electron microscopy (TEM) of individual 
nanoparticles (Figure 19). This provided a direct measure of the domain size, as 
discernible from grain-boundaries between tetrahedra within the particle 
ultrastructure.84 Measurements of the average domain size from TEM agreed well with 
the crystallite size calculated with the Rietveld method. In TEM, a five-fold symmetry 
of the domains was observed, indicating that the particles actually consist of 
pentagonal bipyramids. Within extended reaction time, triangular platelets and also few 
rod-like particles evolved. Both appeared to consist of only one crystallographic 
domain. This sharply contrasted with the spherical particles which are always twinned. 
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There were no non-twinned spherical particles observed, which indicates that twinning 
occurs very early during the nucleation. 
 
Figure 19: Representative TEM images of silver nanoparticles synthesized under 
reflux and ambient light exposure after 15 min (A; diameter 20 nm/domain size 6 nm), 
42 min (B; 35 nm/11 nm); 65 min (C; 48 nm/18 nm); 350 min (D; 65 nm/21 nm). E 
shows a representative image of a triangular particle and F presents a representative 
image of a rod-like particle. 
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The effects of the reducing agent glucose and the capping agent PVP were not 
investigated in this study. However, these are standard synthetic conditions and 
reagents which often lead to nanoparticles with different sizes and shapes.85-88 Our 
results showed that there were considerable dynamics in the system, up to about 1000 
min reaction time. Nucleation appeared to occur in the early stages, with an imprint of 
the final morphology: sphere (in fact: pentagonal twin) or triangle. These initially formed 
nuclei (or seeds) grew with time by attracting more silver ions from the solution, but 
their internal crystallographic structure remained the same. The different growth rates 
of spheres and triangles had to be related to different kinetics of reduction of silver ions 
and subsequent attachment onto the silver particle surface.  
For most wet-chemical synthesis procedures, adequate information about size, 
morphology or dispersity is needed to tailor the synthesis conditions by manipulating 
the reagents or physical impact during synthesis.77, 84, 86-90 There is a high need to 
provide a correlation between the final morphology of nanoparticles and the preferred 
experimental parameters by analyzing particle ultrastructural and crystallographic 
growth. 
Based on the results, it can be concluded that the reduction of silver with glucose in 
the presence of PVP mostly led to spherical nanoparticles, but triangles also occurred 
at a very early stage. Their fraction grew with increasing reaction time. Moreover, a 
few rod-like particles were observed at later stages. It is remarkable that both spherical 
and triangular particles continued to grow during synthesis, and that they seemed to 
originate from different nucleation events. After about 1000 min, the dynamics of the 
system appeared to have ceased. It was demonstrated that the increase in domain 
size was proportional to particle size. The nanoparticles just grew in size together with 
their domains. The silver lattice unit cell parameter a was significantly increased in the 
nanoparticles by about 0.002 Å. Neither air exposure nor ambient light had a significant 
effect on the reaction products.  
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Adapted with permission from S. Banerjee, K. Loza, W. Meyer-Zaika, O. Prymak, 
M. Epple, "Structural evolution of silver nanoparticles during wet-chemical synthesis", 
Chemistry of Materials 26 (2014) 951-957. Copyright (2015) American Chemical 
Society. 
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5.3 Behavior of silver compounds in biological media 
Silver is increasingly used as a biocidal agent in many applications.11, 16, 59, 91-97 To 
meet the diversity of application types, different kinds of silver compounds have been 
developed to serve this market. However, there are increasing concerns about 
potential risks to humans and the environment, especially in the case of silver 
nanoparticles.3, 7, 98-102 The most potent compounds for a high silver release are soluble 
silver salts like silver nitrate or silver acetate. These are fully water-soluble with a high 
rate of silver ion release. They are often used in cell culture experiments to elucidate 
the biological effect of silver.31, 61, 93, 102-112 In these cases, it is tacitly assumed that the 
concentration of free silver ions is the same as that of the added silver salts. This 
obviously cannot be the case, because a whole set of proteins, biomolecules and 
inorganic ions like chloride and phosphate is present in the biological medium. These 
will react with silver ions in one way or another, reducing the concentration of dissolved 
silver ions, as pointed out by a number of authors.30, 103, 108 This is also true for 
engineered silver nanoparticles after their release into the environment.7, 107, 109, 113 
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Figure 20: Schematic representation of possible interactions of silver ions (released 
from silver nanoparticles or from soluble silver salts) with components of biological 
media. 
Figure 20 shows possible predicted reactions that can occur in complex media: 
• precipitation of silver phosphate in the presence of phosphates, 
• precipitation of silver chloride in the presence of chloride, 
• reduction silver ions by sugar molecules, 
• complex formation of the silver ions with a variety of biomolecules within a cell, 
e.g., nucleic acids, lipids or sulfhydryl groups of metabolic enzymes. 
Here, the behavior of silver compounds was addressed in biologically relevant 
concentrations in different media, from physiological salt solution over phosphate-
buffered saline solution to cell culture media. X-ray diffraction methods were used for 
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sample characterization as a non-destructive analytical technique to reveal information 
about the crystallographic structure, chemical composition, and physical properties of 
centrifuged reaction products during the interaction between silver ions and the 
constituents of biological media. By scanning electron microscopy, information was 
obtained about the surface morphology and elemental composition of the resulting 
products (energy-dispersive X-ray spectroscopy) after the interaction of silver nitrate 
with biological media that also contain proteins.  
5.3.1 Immersion experiments of silver nitrate in biological media 
As a model system of free silver ions silver nitrate was added to different biological 
media with silver ion concentrations between 0.01 g L-1 and 0.1 g L-1 (10 to 100 ppm). 
This was the typical range for biological studies using silver.11, 31 The solutions of silver 
nitrate were stirred at room temperature for 7 days under sterile conditions. Light was 
not explicitly excluded. The isolation of possible products was accomplished by 
ultracentrifugation. 
The results are summarized in Table 2 and show that silver ions, initially present as 
silver nitrate, were mainly precipitated as AgCl if chloride was present. In all cases, 
sub-microparticles of silver chloride were found. The only exception was the aqueous 
solution of glucose in the absence of chloride (i.e. a reducing agent), where metallic 
silver was found. Glucose was able to reduce Ag+ to Ag0. Silver phosphate was not 
observed in any case, probably due to the moderate pH (around 7) at which phosphate 
is mostly protonated to hydrogen phosphate and dihydrogen phosphate. In the 
absence of biomolecules, the silver chloride crystals were able to grow until the 
supersaturation was consumed by crystallization. No metallic silver was found by X-
ray diffraction together with silver chloride, indicating that any reduction (e.g., by light) 
was either minor or absent. The equilibrium concentration of free ionic silver can be 
calculated using the solubility product of AgCl (1.7∙10-10 mol2 L-2).11 
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Table 2: Nature of the formed solid, isolated by ultracentrifugation, after adding silver 
nitrate at a silver concentration of 0.1 g L-1 (100 ppm) and stirring for 7 days at room 
temperature. The particles were analyzed by SEM, EDX and XRD. The maximum 
possible amount of dissolved free Ag+ in equilibrium was calculated by the chemical 
equilibrium software Visual MinteQ 3.0. 
Medium (aqueous solutions) Size of the particles 
by SEM / nm 
Maximum possible 
concentration of Ag+ in the 
immersion medium / µg L-1 
Concentration 
of Cl- / mol L-1 
glucose (2 g L-1) 50..100 (Ag0) - 0 
NaCl (0.9%) 300..1000 (AgCl) 0.225 0.154 
NaCl (0.9%) + glucose (2 g L-1) 700..1500 (AgCl) 0.225 0.154 
PBS 500..1000 (AgCl) 0.250 0.139 
PBS + glucose (2 g L-1) 800..1500 (AgCl) 0.250 0.139 
RPMI 1640 medium + 10% FCS 200..350 (AgCl) 0.327 0.108 
LB medium 30..50 nm (AgCl) 0.372 0.085 
 
The dispersed particles were also detected by nanoparticle tracking analysis (NTA) in 
RPMI + 10% FCS (Figure 20). The measurement was performed after incubation of 
silver nitrate for 10 min. This was not possible in Lysogeny Broth (LB) medium due to 
the its high turbidity and the small silver chloride crystals. For primary systems (solvent 
without silver nitrate) and the reaction products (after addition of silver salt), 
experimental data based on nanoparticle tracking analysis were used to determine the 
size distribution profile of such small particles in suspension. The initial components 
were silver nitrate and cell culture medium supplemented with fetal calf serum. The 
resulting reaction products were likely to be present in the colloidal state, because of 
the presence of biomolecules, like proteins. It is probable that a protein corona 
prevented formed products from agglomerating. In biological fluids, proteins bind to the 
surface of nanoparticles to form a coating known as the protein corona, which can 
critically affect the interaction of nanoparticles with living systems. Since physiological 
systems are highly dynamic, it is important to obtain a time-resolved knowledge of 
protein-corona formation.114 
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Figure 20: Particle size distribution and representative scattering image (right corner) 
from 10 µg mL-1 Ag+ (10 ppm) after 10 min incubation in RPMI + 10% FCS. In the 
control experiment (pure RPMI + 10% FCS), no scattering particles of this size were 
observed. 
Figure 21 shows SEM images of AgCl nanoparticles, isolated from phosphate-buffered 
saline (PBS) (i.e. no protein present) and Lysogeny Broth (LB) medium, respectively. 
LB medium is a nutritionally rich medium used for the growth of bacteria. The typical 
formulation of LB medium contains peptides and casein peptones, vitamins, trace 
elements (e.g., sulfur, magnesium), and minerals (sodium chloride). On the other hand, 
PBS is a salt solution containing sodium phosphate, sodium chloride, potassium 
chloride, and potassium phosphate. The isolated particles from LB medium were 
around 30-50 nm, most likely due to the presence of a protein corona, which inhibits 
the further growth of crystals.115-125 The morphology of isolated particles from protein-
containing media was difficult to determine due to the resolution limit of SEM and the 
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residual organic matrix. However, particles isolated from PBS showed the morphology 
typical of synthetic silver chloride. 
  
Figure 21: Representative scanning electron micrographs of silver chloride 
nanoparticles, isolated from PBS (no proteins present; left) and LB medium (high 
protein concentration; right).  
Figure 22 shows X-ray diffractograms of the products isolated from LB medium and 
PBS. The identified phase was silver chloride. For this, the formed particles were 
isolated by ultracentrifugation and redispersion in pure water. As mentioned before, 
neither elemental silver nor silver phosphate was detectable. Notably, the narrow 
diffraction peaks corresponded to sub-microparticles isolated from PBS. These result 
were in good agreement with scanning electron microscopy (Figure 22), while a 
characteristic peak broadening gave information about the crystallite size. 
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Figure 22: Representative X-ray powder diffractograms of precipitates isolated from 
LB medium (upper pattern) and PBS (lower pattern). The silver chloride peaks are 
denoted by red bars (PDF No. 00-031-1238) 
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5.3.2 Immersion experiments of silver nanoparticles in biological media 
In order to better understand the processes during immersion, the studies were 
extended by mixing silver nanoparticle dispersions with media of increasingly biological 
nature and studying the (nano-)particulate reaction products. As a model for 
engineered particles, PVP-coated silver nanoparticles were used. The detailed 
characterization of the nanoparticles was described in Chapter 5.2. The dispersions 
were stirred for equilibration (7 days) and then subjected to ultracentrifugation. All 
precipitates and nanoparticles were isolated by this method and then analyzed by 
scanning electron microscopy, energy-dispersive X-ray spectroscopy and X-ray 
powder diffraction. This gives an essential view on all the particulate species that are 
present after immersion. Table 3 summarizes the results. The original silver 
nanoparticles were found to be practically unaffected after the immersion, indicating 
that they had only partially dissolved. It is important to mention that the gravimetric 
determination of the amount of precipitate was impossible due to the very small amount 
(about 10-100 mg from 1 L of dispersion).  
Table 3: Results of the immersion experiments after 7 days. PVP-stabilized silver 
nanoparticles were used at a concentration of 0.1 g L-1. All solid products were isolated 
by ultracentrifugation. The possible amount of dissolved Ag+ was calculated by the 
chemical equilibrium software Visual MinteQ 3.0. 
Medium Diameter of the particles by 
SEM / nm 
Maximum possible 
concentration of Ag+ 
in the immersion 
medium / µg L-1 
Concentra-
tion of Cl-/ 
mol L-1 
glucose (2 g L-1) Ag (70 nm) N/A 0 
NaCl (0.9%) Ag (70 nm), AgCl (400-800 nm) 0.225 0.154 
NaCl (0.9%) + glucose (2 g L-1) Ag (70 nm), AgCl (200-500 nm) 0.225 0.154 
PBS Ag (70 nm), AgCl (200-300 nm) 0.250 0.139 
PBS + glucose (2 g L-1) Ag (70 nm), AgCl (200-500 nm) 0.250 0.139 
RPMI medium +10% FCS Ag (70 nm), AgCl (110-140 nm) 0.327 0.108 
LB medium Ag (70 nm), AgCl (250-300 nm) 0.372 0.085 
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In the case of silver nanoparticles, the situation was very similar to that resulting from 
the immersion of soluble silver salt in biological media. The released silver ions were 
mainly precipitated as AgCl if chloride is present. The maximum concentration of silver 
was computed in the presence of various inorganic ions and it was found that less than 
1 µg of silver per liter may be present in thermodynamic equilibrium. This neglect both 
the influence of organic species that may act as coordinating ligands, and a possible 
non-equilibrium state of the dispersion.126, 127 The initially present silver nanoparticles 
were recovered in all cases. Silver phosphate was not observed in any case, probably 
due to the moderate pH (around 7) at which phosphate is mostly protonated to 
hydrogen phosphate and dihydrogen phosphate.  
  
Figure 23: Scanning electron micrograph (left image) and energy-dispersive X-ray 
spectrum (right image) of products isolated from PBS solution after the immersion of 
silver nanoparticles.  
Figure 23 shows particles isolated from PBS and their elemental composition. PVP-
coated silver nanoparticles remained unchanged. This was supposedly due to the 
similar particle distribution before and after immersion. On the micrograph, some 
secondary formed particles were present. The particle morphology was typical for 
silver chloride crystals. The EDX spectrum revealed the presence of silver and 
chlorine. The signals of Si and Au resulted from the background and sputtering of 
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samples prior to microscopy, respectively. The carbon and oxygen peaks can be 
attributed to the polymer content of PVP-coated silver nanoparticles, since these 
elements were also present in the EDX spectrum of silver nanoparticles from the 
aqueous solution (see Chapter 5.2).  
 
Figure 24: X-ray powder diffractogram of particles isolated from RPMI + 10% FCS 
medium. Peaks of silver chloride and elemental silver are denoted by red and blue 
bars, respectively. An asterisk corresponds to sodium chloride peak.  
X-ray powder diffractogram of particles isolated from RPMI + 10% FCS medium is 
displayed in Figure 24. Although the samples were proceeded to a wash step, the peak 
of sodium chloride was still present. The elemental silver and silver chloride were 
present.  
* 
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Figure 25: Representative scanning electron micrographs of particles isolated from 
RPMI + 10% FCS medium after immersion.  
 
Figure 26: Energy-dispersive X-ray spectrum of particles isolated from RPMI + 10% 
FCS medium after immersion.  
Results and discussions 
 
 
71 
 
 
Micrographs (Figure 25) show isolated silver nanoparticles and secondary formed 
particles after incubation in RPMI + 10% FCS medium. The particles with cubic 
morphology were detectable. Silver chloride crystallizes typically in cubic morphology. 
The high content of proteins made the analysis complicated, while the isolated 
precipitates were covered with serum from the medium. The EDX spectrum showed 
the signal from silver and chlorine (Figure 26). The silicon signal was from the 
background, and gold came from sputtering of samples prior to microscopy. The 
carbon and oxygen peaks could be attributed to the polymer content of PVP-coated 
silver nanoparticles as well as to residual proteins from the immersion experiments.  
In conclusion, in chloride-containing media, silver ions were mostly precipitated as 
silver chloride (Figure 27). If high amounts of proteins were present, as it is usually the 
case in cell culture media and biological fluids (e.g., blood), the silver chloride particles 
remained in nanoparticulate state, surrounded and preserved by a protein corona, 
which prevented further growth of crystals.  
 
Figure 27: Schematic representation of the interactions of silver ions with components 
of biological media. 
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5.3.3 Characterization of PVP-coated silver chloride nanoparticles 
Since most of the cell culture studies using silver ions as a control are actually studying 
the influence of colloidal silver chloride on the cells, comparable particles which are 
colloidally stable in biological media were prepared.  
Synthetic silver chloride particles were obtained by precipitation in the presence of 
PVP. Here, PVP was needed to enhance the colloidal stability of formed particles. 
Before characterization, the dispersions were subjected to ultracentrifugation, to 
remove the polymer excess and by-products (sodium nitrate). The purified PVP-coated 
silver chloride nanoparticles were analyzed by dynamic light scattering, scanning 
electron microscopy, and energy-dispersive spectroscopy. All samples were stored at 
4 °C in the dark until further analysis. Storage under light exclusion is necessary, as 
silver chloride is known to be a photosensitive material and may rapidly darken on 
contact to light by decomposing into elemental chlorine and metallic silver.  
The mean particle size was around 120 nm as measured in aqueous dispersion by 
dynamic light scattering (Figure 28). The PVP-coated silver chloride nanoparticles 
possessed a zeta potential of -42 mV, indicating electrosteric stabilization. The surface 
charge could be a consequence of adsorbed anions (i.e, Cl-). Figure 28 shows 
representative micrographs of prepared silver chloride nanoparticles. The resulting 
morphology was very similar to that of particles isolated from PBS. The edge length of 
the synthetic PVP-coated silver chloride cubic nanoparticles was about 100 nm, as 
measured by electron microscopy.  
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Figure 28: Representative electron micrograph of synthesized AgCl-PVP 
nanoparticles (left) and the associated particle size distribution (by number) 
determined by DLS in ultrapure water (right). 
Synthetically prepared silver chloride nanoparticles were stable in cell culture medium 
RPMI + 10% FCS at least for a week, which is sufficient for further biological 
investigations. Their stability was estimated by dynamic light scattering, plotting 
hydrodynamic diameter and time of incubation. 
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Figure 29: DLS measurements of synthetic AgCl-PVP nanoparticles, dispersed in 
RPMI + 10% FCS medium at 37 °C under sterile conditions up to 150 h. No 
precipitation or coagulation was observed. 
5.3.4 Characterization of fluorescent silver chloride nanoparticles 
To study the cellular uptake of synthetically prepared silver chloride, nanoparticles 
were treated with the organic dye fluorescein. In particular, silver chloride nanoparticles 
were synthesized in the presence of poly(ethylenimine) (PEI) and additionally 
functionalized by fluorescein. Then, the dispersion was purified by ultracentrifugation 
and redispersion in ultrapure water by sonication. Thereby Cl-, excess PEI, and excess 
Ag+ were all removed. All samples were stored at 4 °C in the dark until further analysis. 
The storage under light exclusion is necessary because of the photochemical 
decomposition of AgCl to elemental silver and chlorine. 
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Scanning electron micrograph shows fluorescent silver chloride nanoparticles with 
typical cubic morphology and an edge length of about 80 nm. The success of 
functionalization with the organic dye was confirmed by fluorescence spectroscopy. 
The emission spectrum is characteristic for fluorescein.128  
 
Figure 30: SEM image of AgCl nanoparticles, stabilized with PEI and labelled with 
fluorescein (left) and a corresponding fluorescence spectrum (right), excitation 
wavelength 490 nm. 
Table 4 summarized the characterization data of the synthesized silver chloride 
nanoparticles in comparison to those formed in the biological media. The size of 
particles formed in media varied from 30 to 350 nm, depending on immersion medium. 
Synthetically prepared particles were of the same magnitude. It is the important to note 
that fluorescent silver chloride nanoparticles were highly positively charged due to the 
functionalization with PEI. This should be taken into account for the discussion of 
biological experiments, where the nanoparticle surface charge is significant for 
investigation of cellular uptake.129 
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Table 4: Colloid-chemical data of silver chloride particles, both isolated from biological 
media and synthetically prepared as colloidal dispersion in ultrapure water. Note that 
not all data were accessible for particles in biological media due to practical constraints 
(mainly the turbidity in solutions with high protein content). 
 Size by DLS / 
nm 
Size by SEM / 
nm 
Zeta potential / 
mV 
Size by NTA / 
nm 
AgCl in LB - 30..50 - - 
AgCl in RPMI+10% FCS - 200..350 - 50..350 
AgCl-PVP 120 100 -42 110 
AgCl-PEI-Fl 220 80 +67 180 
 
5.3.5 Toxicity of silver chloride nanoparticles towards cells and bacteria 
The data showed that the released silver ions precipitated mostly as AgCl in biological 
media, and that most cell culture studies where silver ions were used as a control were 
in fact studying the effect of colloidal silver chloride on the cells. To prove this 
assumption, human mesenchymal stem cells (hMSCs), monocytes, and T-cells were 
cultured in the presence of synthetically prepared silver chloride nanoparticles, and the 
viability of the cells was analyzed by fluorescence microscopy. The viability was 
evaluated by calcein-AM assay. As a control, silver acetate was used in cell culture 
media in the same concentration range as synthetically prepared silver chloride 
nanoparticles. Antimicrobial studies were performed on the relevant bacterial strain S. 
aureus. This bacterial strain is gram-positive bacterium and is often found in the 
respiratory tract and on the skin.  
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Figure 31: Cytotoxicity of ionic silver (silver acetate) and PVP-stabilized AgCl 
nanoparticles towards hMSCs (A), monocytes (B), and T-cells (C). Cells were treated 
with different concentrations of silver acetate and PVP-coated silver chloride 
nanoparticles (normalized to the same silver concentration) for 24 h under cell culture 
conditions, respectively.  
Figure 31 shows the concentration-dependent silver toxicity without significant 
differences between different cell lines. Viable hMSCs were quantified by digital image 
processing (phase analysis). T-cell and monocyte viability were determined by 
measuring the cell number: counting cell events for 30 s under constant flow. The data 
were expressed as mean±standard deviation (N=3) given as the percentage of the 
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control (cells cultured without silver). An asterisk (*) indicates significant differences in 
comparison to the control (* p<0.05, ** p<0.01, *** p<0.001).  
A similar effect was also observed for bacterial strains. The characteristic data of 
antimicrobial tests are shown in Table 5. 
Table 5: Cytotoxicity of ionic silver (silver acetate) and PVP-stabilized AgCl 
nanoparticles towards S. aureus. The antibacterial effect against S. aureus was 
analyzed by measuring the minimal bactericidal concentration (MBC). 
 Silver acetate (N = 3) AgCl nanoparticles (N = 3) 
Cell density / mL-1 MBC / µg mL-1 Ag MBC / µg mL-1 Ag 
1·103 2.0 2.0 
1·104 2.0 2.5 to 2.0 
1·105 2.5 5.0 
1·106 5.0 5.0 
 
It is interesting that there is no significant difference between the biological action of 
silver ions and silver chloride nanoparticles towards eukaryotic cells and bacteria. As 
shown earlier, the cytotoxic concentration of silver acetate against eukaryotic cells and 
bacteria (E. coli) is in the same concentration range, and gram-negative bacteria are 
affected by silver ions in the same way as gram-positive bacteria.11, 31 This underscores 
the presence and biological effect of dispersed AgCl nanoparticles in both cases. 
Finally, fluorescing nanoparticles of silver chloride were prepared to follow their 
pathway into cells. HeLa cells were chosen as a suitable model cell line.  
Figure 32 shows the cellular uptake into HeLa cells which occurred within a few hours 
under cell culture conditions. The green fluorescence was from fluorescein, which was 
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used for nanoparticle labeling. The particles were accumulated in the perinuclear 
region. It may be assumed that the uptake occurred by endocytosis as in the case of 
other nanoparticles.130-132 
 
Figure 32: Cellular uptake of fluorescein-labelled AgCl nanoparticles by HeLa cells 
after 4 h under cell culture conditions. Prior to imaging, the cells were washed twice 
with PBS. Imaging was performed on unfixed cells. Fluorescently-labelled silver 
chloride nanoparticles show up in green. Light microscopy (A), fluorescence 
microscopy (B), and overlay (C) of cells with nanoparticles. Scale bar is 20 µm.  
A final question remains: What is the origin of the cytotoxic effect of the AgCl 
nanoparticles? Obviously, it is important to differentiate the cytotoxic effect between 
bacteria and eukaryotic cells. The uptake of nanoparticles by bacteria is limited by the 
size of the particles (1-10 nm).26, 30, 133 The attachment of these particles to the surface 
of gram-negative bacteria may disrupt the permeability. Moreover, they may be 
capable of entering the cell membrane and causing further damage to a variety of 
biomolecules (e.g., by binding to sulfur-containing molecules or by the release of silver 
ions).26, 30, 133 Thus, AgCl can be effective from the outside (e.g., by disrupting the 
bacterial cell membrane), and also by inducing internal collateral damage like the 
formation of reactive oxygen species.26 Here, the larger silver chloride nanoparticles 
found or prepared act from inside the eukaryotic cells due to the release of silver ions, 
as recently shown for silver nanoparticles.129 It is interesting that Zhang et al. have 
shown that AgCl was less cytotoxic to red blood cells and human mesenchymal stem 
cells compared to the other silver materials tested. In addition, a decline in the 
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cytotoxicity of AgCl at significantly high concentrations was observed. This was 
attributed to the reduction of cytotoxicity of aggregated AgCl which limited the 
bioavailability of free Ag+ ions, which is not true in our case.108  
If AgCl nanoparticles are taken up into eukaryotic cells by endocytosis, they appear in 
the lysosome under acidic conditions. In principle, the solubility of AgCl should not 
depend on pH, with HCl being a strong acid. The conditions inside a lysosome were 
simulated, using the software Visual MinteQ 3.0. As a lysosomal liquid, hydrochloric 
acid was used with a pH of 5.134 The calculation was performed for 100 µM silver 
chloride. In this case, about 10% of the AgCl is present in solution as silver ion Ag+, 
with a small amount of the chloro-complex [AgCl2]- that is also present. Therefore, the 
question of whether AgCl fully dissolves in lysosomes cannot yet be answered. Except 
for the formation of the chloro-complex and the unknown degree of complexation by 
biomolecules and proteins, the solubility of AgCl should not be increased inside a 
lysosome. However, it must be stressed that the solubility product for AgCl was derived 
for macroscopic crystals. As nanocrystals have a much higher specific surface area, 
their solubility will generally be higher, and hence their cytotoxicity will be higher than 
that of AgCl microcrystals. 
These considerations should also apply to environmental systems like salt water with 
high chloride content, provided that biomolecules are present to form a stabilizing 
corona around the nanoparticles.104, 135, 136 
Cell biological experiments were performed by Jun.-Prof. Dr. C. Sengstock and 
Dr. S. Chernousova. 
Adapted from K. Loza, C. Sengstock, S. Chernousova, M. Köller, M. Epple, "The 
predominant species of ionic silver in biological media is colloidally dispersed 
nanoparticulate silver chloride", RSC Advances 4 (2014) 35290–35297 Published by 
The Royal Society of Chemistry. 
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Adapted from K. Loza, J. Diendorf, C. Sengstock, L. Ruiz-Gonzalez, J. M. Gonzalez-
Calbet, M. Vallet-Regi, M. Köller, M. Epple, "The dissolution and biological effects of 
silver nanoparticles in biological media", Journal of Materials Chemistry B 2 (2014) 
1634–1643 Published by The Royal Society of Chemistry. 
5.3.6 Quantification of dissolved species of silver compounds in biological 
media 
Silver nanoparticles are widely used due to their antibacterial action in consumer 
products and in medicine.6, 11, 16, 59, 91, 93, 94, 99, 137, 138 However, there is increasing 
evidence that the release of silver ions from nanoparticles is responsible for this 
biological effect. Xiu et al. showed in a very sophisticated way that silver nanoparticles 
did not show a bactericidal effect if the bacteria were cultivated under anaerobic 
conditions, i.e. when no dissolution of the nanoparticles occurred.61 Studies on the 
dissolution behavior were reported in a number of publications,33, 61, 69, 106, 107, 109, 117, 
138-147 but there is no agreement on the dissolution behavior in more complex media 
(e.g., in biological systems and in the environment).  
Based on our earlier results on the dissolution of dispersed silver nanoparticles in pure 
water,60, 69 the studies were extended to more complex media. The dissolution kinetics 
of the silver nanoparticles were analyzed after immersion in DMEM medium 
supplemented with 10% FCS. Table 6 summarizes the results of dissolution 
experiments from the literature. The typically applied methods for silver determination 
are AAS or ICP-MS. The separation of silver nanoparticles and silver ions is typically 
accomplished by dialysis or nanofiltration. Despite the fact that there are a number of 
studies where the dissolution kinetics of dispersed silver nanoparticles were measured, 
they are practically incomparable (Table 1). The nanoparticle properties were quite 
different (e.g., size, charge, functionalization), and it is very likely that this strongly 
influences the dissolution performance. Additionally, the immersion media were 
different and not easily comparable between the individual data points. Finally, it could 
be safely assumed that the total silver concentration will influence the dissolution 
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process, as critical factors like the solubility product of silver chloride or the reduction 
potential of silver ions directly depend on the concentration. However, some 
conclusions can be drawn, mainly by comparing results within one set of experiments, 
i.e. from one reference. 
Liu et al. described the dissolution of silver nanoparticles in acetate buffer in the 
presence of citrate anions, sodium sulfide and 11-mercaptoundecanoic (MUA) acid 
and found that sulfidation and MUA reduced the dissolution rate to undetectable 
values.139 They also investigated the role of humic and fulvic acid, dissolved oxygen, 
natural and low salt sea water and showed that the addition of organic matter can 
suppress the release of silver ions.139 Levard et al. investigated the role of a surface 
sulfidation process and found that at a high ratio of sulfur to silver, the released silver 
content decreased to hardly detectable values.144 Zook et al. measured the dissolution 
in cell culture medium (DMEM) and found a fractional dissolution of different polymer-
coated silver nanoparticles. The dissolution was enhanced in biological media in 
comparison to inorganic salt solutions, which is probably due to complexation of the 
released silver ions.109 Zhang et al. considered size effects on the dissolution kinetics 
in quarter-strength Hoagland medium and concluded that release rate depends on size 
and concentration. Smaller particles were found to dissolve faster.145 The fate of silver 
nanoparticles in synthetic gastric fluid and wound fluid was studied by Liu et al. They 
reported a rapid dissolution in gastric acid in comparison to pseudoextracellular fluid 
and also found an interaction with thiol- and selenide-containing biomolecules. They 
proposed the formation of secondary thiol- and selenide-containing nanoparticles after 
partial dissolution in the gastrointestinal tract.113
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Table 6: Results of dissolution experiments of silver nanoparticles. Room temperature means 25 °C. Citrate-stabilized nanoparticles 
can be assumed to have a negative zeta potential, but this was not always stated in the references. The immersion medium was water 
in all cases with the stated additives. All experiments were carried out at neutral pH, unless specified otherwise.60 
Functionalization of 
silver nanoparticles 
Diameter 
/ nm 
Zeta 
potential 
/ mV 
Silver con-
centration 
/ g L-1 
Tempe-
rature / °C 
Immersion medium Immer-
sion 
time / h 
Degree of 
dissolu-
tion / % 
Ref. 
Citrate 85 -30 0.32 25 Water 336 15 69 
Citrate 85 -30 0.14 25 Water 410 12 69 
Citrate 85 -30 0.32 37 Water 307 56 69 
Citrate 85 -30 0.14 37 Water 444 53 69 
Citrate 4.8 -45 0.002 25 Air-saturated distilled water, [O2]=9.1 mg L-1; pH=5.68 3000 ~100 139 
Citrate 4.8 -45 0.0002 25 Air-saturated distilled water, [O2]=9.1 mg L-1; pH=5.68 240 ~100 139 
Citrate 4.8 -45 0.00005 25 Air-saturated distilled water, [O2]=9.1 mg L-1; pH=5.68 120 ~100 139 
Citrate 4.8 -45 0.00005 4 Air-saturated distilled water, [O2]=9.1 mg L-1; pH=5.68 120 36 139 
Citrate 4.8 -45 0.00005 37 Air-saturated distilled water, [O2]=9.1 mg L-1; pH=5.68 120 96 139 
PVP 50 -17 0.22 5 Water 411 9 69 
PVP 50 -17 0.1 5 Water 149 8 69 
PVP 50 -17 0.05 5 Water 149 12 69 
PVP 50 -17 0.35 25 Water 134 48 69 
PVP 50 -17 0.1 25 Water 81 52 69 
PVP 50 -17 0.05 25 Water 42 43 69 
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PVP 50 -17 0.35 37 Water 27 52 69 
PVP 50 -17 0.1 37 Water 27 89 69 
PVP 50 -17 0.05 37 Water 11 68 69 
PVP 70 -22 0.35 25 Oxygen-free water 1660 2 60 
Citrate 4.8 -45 0.00005 25 Natural seawater, pH=7.90 192 38 139 
Citrate  20 - 0.0003 25 Modified ¼ Hoagland medium, [O2]=7.8 mg L-1; pH=5.6 336 40 145 
Citrate 20 - 0.0006 25 Modified ¼ Hoagland medium, [O2]=7.8 mg L-1; pH=5.6 336 29 145 
Citrate  40 - 0.0003 25 Modified ¼ Hoagland medium, [O2]=7.8 mg L-1; pH=5.6 336 21 145 
Citrate  40 - 0.0006 25 Modified ¼ Hoagland medium, [O2]=7.8 mg L-1; pH=5.6 336 20 145 
Citrate  80 - 0.0003 25 Modified ¼ Hoagland medium, [O2]=7.8 mg L-1; pH=5.6 336 10 145 
Citrate  80 - 0.0006 25 Modified ¼ Hoagland medium, [O2]=7.8 mg L-1; pH=5.6 336 8 145 
PVP 70 -22 0.35 25 0.9% NaCl  3670 8 60 
PVP 70 -22 0.35 25 PBS 3670 4 60 
PVP 39 negative 1 25 0.01 M NaNO3, pH=7 720 1.9 144 
PVP, sulfidated 39 negative 1 25 0.01 M NaNO3, pH=7 730 ca. 0 to 
0.27 
144 
PVP 70 -22 0.35 25 10 mM H2O2 1821 90 60 
Citrate 4.8 -45 0.002 25 Acetate buffer, pH 5.6 24 15 139 
Citrate 4.8 -45 0.002 25 Acetate buffer, 0.4 mM citrate; pH 5.6 24 9 139 
Citrate 4.8 -45 0.002 25 Acetate buffer, 10 mM citrate; pH 5.6 24 7 139 
         
Citrate 4.8 -45 0.002 25 Acetate buffer, 0.4 mM Na2S; pH 5.6 24 <1 139 
Citrate 4.8 -45 0.002 25 Acetate buffer, 4 mM 11-mercaptoundecanoic acid; pH 
5.6 
24 ca. 0 139 
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PVP 70 -22 0.35 25 1 g L-1 cysteine  4366 ca. 0 60 
PVP 70 -22 0.35 25 1 g L-1 glucose 4366 61 60 
Citrate 4.8 -45 0.00005 25 Boric acid and bicarbonate low ionic strength seawater 
buffer, pH=7.90 
192 54 139 
Citrate  23 - 0.005 25 DMEM 22 ca. 75 109 
Citrate  23 - 0.1 25 DMEM 22 ca. 7 109 
PVP 23 - 0.005 25 DMEM 22 ca. 76 109 
5 kDa PEG  23 - 0.005 25 DMEM 22 ca. 83 109 
20 kDa PEG  23 - 0.005 25 DMEM 22 ca. 75 109 
Dextran 23 - 0.005 25 DMEM 22 ca. 67 109 
5 kDa PEG 23 - 0.1 25 DMEM 22 ca. 11 109 
20 kDa PEG 23 - 0.1 25 DMEM 22 ca. 9 109 
PVP 4-5 negative 0.005 37 Synthetic gastric acid, pH=1.12 24 ~98 113 
PVP 4-5 negative 0.005 37 Pseudoextracellular fluid, pH=7.52 24 ~80 113 
 
Adapted from K. Loza, J. Diendorf, C. Sengstock, L. Ruiz-Gonzalez, J. M. Gonzalez-Calbet, M. Vallet-Regi, M. Köller, M. Epple, "The 
dissolution and biological effects of silver nanoparticles in biological media", Journal of Materials Chemistry B 2 (2014) 1634–1643 
Published by The Royal Society of Chemistry. 
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5.3.6.1 Determination of silver nanoparticle dissolution in Dulbecco's modified 
Eagle's medium supplemented with 10% fetal calf serum by atomic 
absorption spectroscopy  
Since the silver ions are responsible for toxic effects in biological systems, the 
evaluation of the dissolution kinetic of silver nanoparticles is required. As described 
above, many studies have been performed in different media. Moreover, it was 
possible to show that the predominant species of silver ions interacting with cell culture 
components is nanoparticulate silver chloride. However, the previously used analytical 
protocols are unable to differentiate between various silver species.109 Therefore, a 
new protocol for the determination of silver nanoparticle dissolution was developed. 
The schematic representation is shown in Figure 6. 
PVP-coated silver nanoparticles were incubated in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal calf serum (FCS) at 37 °C. DMEM is 
typically used cell culture fluid for eukaryotic cells and tissue. It contains salts, amino 
acids, vitamins, and glucose. FCS is often used to maintain cell growth. PVP-coated 
silver nanoparticles were characterized in Chapter 5.2 and stored under light exclusion 
at 4 °C before experiments.  
To preserve nanoparticles from unwanted degradation by dissolved oxygen species, 
argon-saturated pure water was used. Ultracentrifugation was used as an effective 
method for the separation of solid compounds from the dissolved species. After a 
certain period, dispersions of possible silver chloro- or protein-complexes were 
separated from nanoparticulate silver chloride and remained silver nanoparticles by 
ultracentrifugation. The residual precipitate (precipitated AgCl and silver nanoparticles) 
was washed to remove the rest of the immersion medium. This was an essential point, 
since residual medium still contained a lot of chloride, which could disrupt further 
analysis. Afterwards, the dispersion was treated with nitric acid (silver dissolves 
completely in nitric acid) to dissolve the remaining silver nanoparticles for further 
quantification. Then, the solution was centrifuged to isolate solid silver chloride. Finally, 
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precipitated silver chloride was treated with ammonia solution to transfer it into soluble 
silver amino complexes. All of the received samples were analyzed by atomic 
absorption spectroscopy (AAS).  
Such a routine procedure provided an overview of silver nanoparticle dissolution in 
complex media. A validation of every experimental point was possible by calculating 
the sample recovery. The recovery level was at 100% for all samples within the 
deviations (standard deviation of the AAS, minimal losses during the washing process, 
pipette deviations). To achieve a reproducible and consistent recovery for all samples, 
some optimization of the analysis process was needed. Firstly, it turned out that in spite 
of strongly basic or acidic solutions, adsorption of silver took place on the vessel walls 
of the polypropylene tube. To avoid these losses, samples were treated by 
ultrasonication.  
Figure 34 shows the dissolution of PVP-functionalized silver nanoparticles over 168 h 
(7 days). The error bars are from the standard deviation of the AAS measurement plus 
the standard deviation of duplicate. 
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Figure 34: The dissolution of PVP-coated silver nanoparticles immersed in DMEM + 
10% FCS at 37 °C. Initial concentration of silver nanoparticles was 50 µg mL-1.  
For 0, 2, and 4 h of incubation an accurate interpretation of the data was difficult, since 
the silver concentrations of the samples were partially below the detection limit of AAS 
(1 µg L-1). Nevertheless, the trend shows that in the first few hours the amount of 
formed silver chloride is higher than the formation of dissolved silver species. After 168 
h, it increases only slightly. 
The initial trend of silver nanoparticle degradation slowly approached a saturation state 
at about 6%. Therefore, around 5.3% of used silver nanoparticles were dissolved after 
a week (equivalent to 2.65 µg mL-1). As a result, 2.2% arose in the form of solid silver 
chloride (1.1 µg mL-1 as Ag or 1.46 µg mL-1 as AgCl) and 3.1% in the form of soluble 
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silver compounds in various dissolved forms in the medium (1.55 µg mL-1). In the 
described literature data (Table 6), silver chloride was out of scope.33, 60, 69, 109, 141, 145 
Nevertheless, in this study, solid silver chloride content was around 42% of dissolved 
silver in cell culture medium after 7 days of incubation.  
In summary, by establishment of the protocol, the dissolution of silver nanoparticles 
was studied including the distinction between formed silver chloride and soluble silver 
species. After 168 h (7 days) of incubation in cell culture medium, the incorporated 
PVP-coated silver nanoparticles were degraded up to 6%. These results were 
consistent with the literature data for similar particle functionalization and size.60, 69 The 
fraction of formed solid silver chloride was around 42% of total silver amount. 
Generally, this method can be also used for different silver particles in chloride-
containing media.  
5.3.6.2 Quantification of soluble silver species in biological media 
In Chapter 5.3.5, the biological investigations of synthetically prepared silver chloride 
nanoparticles were discussed. It was found that toxic effects for silver acetate in 
medium occur in the same concentration range as in synthesized silver chloride 
nanoparticles.148 The results were representative for eukaryotic cells as well as for 
bacterial strains. It was supposed that some dissolution of silver chloride can take place 
in lysosomes. However, the uptake of particles by bacteria is unusual.26, 133 The rate of 
dissolution of silver chloride particles and the bioavailability of soluble silver species 
were also unknown.  
To shed light on the state of silver compounds, the amount of soluble silver species 
was quantified. The quantification procedure was based on atomic absorption 
spectroscopy, since gravimetric analysis was not possible, due to the low 
concentrations. Ultracentrifugation was used to separate soluble silver chloro- or 
protein-complexes from remained particles. Afterwards, the supernatant was treated 
with ammonia solution and proceeded to analysis.  
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Figure 35: Amount of soluble silver species after incubation of PVP-coated silver 
chloride nanoparticles in biological media with different amount of serum. PVP-coated 
particles were incubated for 24 h; initial silver concentrations were 5 and 100 µg mL-1.  
Figure 35 shows the percentage of soluble silver species present in biological media 
with various serum contents after the immersion of engineered PVP-coated silver 
chloride for 24 h at 37 °C. The immersion conditions simulated relevant toxicological 
investigations in order to investigate the protein effect of serum-containing DMEM, 
serum-free DMEM, 10% FCS solution, and phosphate-buffered saline. Alone, DMEM 
medium contains around one weight percent of biomolecules. PVP-coated silver 
chloride nanoparticles were the same as used for biological tests. The physico-
chemical characterization of particles was explicitly described in Chapter 5.2.  
It is notable that after the incubation of PVP-coated silver chloride nanoparticles at a 
silver concentration of 5 µg mL-1 (5 ppm), silver existed as a soluble species if proteins 
were present. In the case of phosphate-buffered saline (no serum), only 20% of 
immersed silver chloride was complexed. As predicted by thermodynamics, the soluble 
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Ag species formed in PBS varied as a function of total Ag and Cl concentration and 
include Ag+, AgCl2−, and AgCl32−. No significant difference is observed between low-
serum and serum-rich environments. However, after incubation of PVP-coated silver 
chloride nanoparticles at a silver concentration of 100 µg mL-1 (100 ppm), the 
dependence of soluble silver on protein content was observed. As shown in Figure 35, 
the higher the serum amount, the more silver was found in supernatant after 
ultracentrifugation. It was likely that these soluble compounds were in the form of silver 
protein complexes. Nevertheless, the identification of such complexes might be a 
challenge, since the exact formulation of fetal calf serum is unknown. FCS is the blood 
fraction remaining after the natural coagulation of blood, followed by centrifugation to 
remove any remaining red blood cells.  
Figure 36 shows the percentage of soluble silver species present in biological media 
with various serum content after the addition of silver nitrate for 24 h at 37 °C. The 
preparation protocol was the same as for synthesized silver chloride nanoparticles. For 
the concentration of 5 µg mL-1 (5 ppm) silver was found in the supernatant if proteins 
were present. A closer look at the data for 100 µg mL-1 (100 ppm) revealed a similar 
trend as PVP-coated silver chloride nanoparticles.  
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Figure 36: The amount of soluble silver species after incubation of silver nitrate in 
biological media with different amounts of serum. Silver nitrate was incubated for 24 h; 
initial silver concentrations were 5 and 100 µg mL-1.  
These results confirmed the effect of serum content on the availability of soluble silver 
species in biological media. It was possible to show that incubation in phosphate- 
buffered saline solution reduced the amount of silver in the supernatant.60, 107, 104, 135, 
136 
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5.3.6.3 Viability of hMSCs treated with silver chloride nanoparticles in 
correlation of fetal calf serum in medium  
 
Figure 37: Fluorescence microscopy images of hMSCs incubated with silver chloride 
nanoparticles cultured in RPMI medium with or without 10% FCS for 24 h at 37 °C. 
Cultured hMSCs in RPMI + FCS (A) or RPMI (B). Cells incubated in RPMI + FCS (C) 
and RPMI (D) containing 2.0 μg mL-1 silver chloride nanoparticles for 24 h. Afterwards, 
the viable hMSCs were stained with calcein-AM.  
The impact of silver chloride nanoparticles in the presence or absence of proteins (fetal 
calf serum; FCS) was analyzed after 24 h. hMSCs were incubated with or without PVP-
coated silver chloride nanoparticles in the presence or absence of protein within the 
cell culture media. The control was not treated with nanoparticles and showed a normal 
cell morphology under the different conditions (Figure 37 A and B). In contrast, an 
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incubation with 2.0 μg mL-1 silver chloride nanoparticles for one day had a strongly 
different outcome. 
Culturing nanoparticles in RPMI-containing FCS and incubation with 2.0 μg mL-1 silver 
chloride for 24 h seemed to have no impact on the hMSCs compared to the control 
(Figure 37 C). On the other hand, excluding FCS incubated with 2.0 μg mL-1 AgCl 
nanoparticles for one day had a strong effect. In all three trials, no viable hMSCs were 
observed under these conditions (Figure 37 D). The quantification of these data is 
summarized in Figure 38.  
 
Figure 38. Viability of human mesenchymal stem cells in the presence of AgCl-PVP 
nanoparticles. The cells were cultured for 24 h with different concentrations of silver 
chloride nanoparticles in the presence (grey bars) or absence (black bars) of 10% FCS 
within the cell culture medium RPMI 1640. Incubations without silver served as controls 
(100%). Living cells were stained by calcein-AM and the fluorescence signals were 
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quantified by digital image processing (phase analysis). Data are expressed as mean 
SD (N=3 independent experiments). * Significant compared to control (p<0.05). 
The question of silver protein complexes remains unclear. Because of the complexity 
of biological systems, there are many possibilities for binding silver. The stability of 
silver (I) complexes varies with the ligand donor atom: N<<P>As>Sb; O<<S~Se~Te; 
F<Cl<Br<I, and Ag (I) has been categorized as a "soft" acid.149 Although it binds most 
strongly to P and S donor ligands, it has an extensive coordination chemistry with N 
(in particular) and O donors, and appears to bind to almost every biological molecule 
tested.149 Silver (I) has long been known to form complexes with amino acids.149 It is 
used to stain proteins in polyacrylamide gels, being more sensitive than staining based 
on Coomassie Blue techniques. When various polyaminoacids were tested, 
polyhistidine was stained the most.150 In certain proteins, silver has been shown to bind 
at specific sites, forming Ag6, Ag12 and Ag18 clusters with a rabbit metallothionein.151 
Because silver (I) tends to complex with so many molecules, it is obviously important 
to consider which interactions may occur between the medium and added AgNO3. A 
decreased biocidal activity in certain media was observed by those working on water 
sterilization.152-154 The effects of different nutrient media have been specifically 
investigated.155 Two silver (I) phosphine complexes exhibited antifungal activity in a 
defined medium, which was lost in a serum-rich medium, and the toxicity of one of 
these complexes toward tumor cells in vitro was reduced by a factor of five by the 
presence of fetal calf serum in the medium.156 The biological effect of PVP-stabilized 
silver nanoparticles and silver ions on human mesenchymal stem cells was studied in 
pure RPMI and also in RPMI - BSA and RPMI - FCS mixtures, respectively. Both 
components considerably increased the cell viability in the presence of silver ions as 
well as silver nanoparticles, indicating  binding of silver by these proteins.117 These 
effects were attributed to the reaction with serum and other components of the 
media.117, 156  
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5.4 Characterization of barium sulfate particles 
Barium sulfate in particulate form is often used as a filler system in coatings (e.g., in 
motor vehicles) due to its mechanical, optical and chemical properties. Lately, BaSO4 
nanoparticles have also been implemented in orthopedic medicine, diagnostic imaging 
and other applications.157-161 Pellethane with integrated BaSO4 nanoparticles showed 
antimicrobial properties in vitro.162 An exposure to aerosolized BaSO4 particles may 
occur during their production, transport, handling, and incorporation into end products, 
as well as during the use and disposal of those products. Chronic exposure to high 
levels of BaSO4 microparticles may induce pneumoconiosis (baritosis) in miners.9, 10, 
163 However, an accurate characterization of the barium sulfate particles used is 
strongly recommended.27 It should include physico-chemical data not only of primary 
particles, but of the secondary formed aggregates after the preparation route or during 
interaction with components of biological media.63 In contrast, for toxicological studies, 
barium sulfate particles were used with primary particles in the nanoscale range added 
as powder with an agglomerate size in the of micrometer range.63, 164-166 It may 
underrate the possible biological responses. To investigate the precise cellular reaction 
to barium sulfate, micro-, sub-micro- and nanoparticles were synthesized. To make the 
tracking of engineered particles possible, a fluorophore was added. Subsequently, an 
explicit characterization was performed to establish a model for toxicologically inert 
particles. 
5.4.1 Characterization of barium sulfate microparticles 
BaSO4 microparticles were synthesized by precipitation of Na2SO4 and Ba(OH)2. The 
feeding of a precursor was performed by a peristaltic pump. Carboxymethylcellulose 
conjugated with 6-aminofluorescein (CMC-F) was used as capping agent. Before 
analysis, the dispersion was purified by ultracentrifugation and then redispersed in 
pure water. In this way excess CMC-F and by-products were separated. The samples 
were stored at 4 °C.  
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Figure 39: Particle size distribution of CMC-F-coated BaSO4 microparticles as 
measured by dynamic light scattering. 
The hydrodynamic diameter of barium sulfate microparticles was measured by 
dynamic light scattering. Figure 39 shows the particle size distribution in water. The 
mean particle diameter was about 1480 nm. The polydispersity index (PDI) was 0.079 
and indicates a monodisperse colloid. The particles were negatively charged with a 
measured zeta potential of -35 mV. A zeta potential different from zero revealed the 
electrostatic nature of colloid stability.  
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Figure 40: Scanning electron microscopy images of CMC-F-coated BaSO4 
microparticles. 
Scanning electron micrographs for barium sulfate (Figure 40) showed spherical micro-
particles. For the estimation of particle size, individual spherical particles were 
analyzed and the results are shown as a histogram (Figure 41). The mean particle size 
assessed by scanning electron microscopy was 1300±210 nm. There was only a slight 
difference between particle diameters measured by dynamic light scattering and 
electron microscopy.  
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Figure 41: Particle size distribution of CMC-F-coated BaSO4 microparticles as 
measured by scanning electron microscopy. 
Energy-dispersive X-ray spectroscopy detected signals of barium, sulfur and oxygen 
(Figure 42). The peak of silicon resulted from the substrate, i.e. a silicon wafer. The 
carbon peak corresponded to carboxymethylcellulose. There were no other signals 
detected. 
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Figure 42: Energy-dispersive X-ray spectrum of CMC-F-coated BaSO4 microparticles. 
Identity and crystallinity of the substances were confirmed using X-ray powder 
diffraction. All materials crystallized in the orthorhombic barite phase. Figure 43 shows 
representative X-ray diffractogram of CMC-F-coated barium sulfate microparticles. All 
of the peaks were readily indexed to a pure orthorhombic crystalline phase of BaSO4, 
which was in good agreement with the literature (PDF No. 00-24-1035). However, the 
received patterns were typical for nanocrystalline materials due to the broadening of 
diffraction peaks. To prove the suggestion, the crystallite size was estimated. The size 
of the crystallites was calculated with the Scherrer equation: 
𝐷 =
𝐾 ∙ 𝜆
𝐹𝑊𝐻𝑀 ∙ 𝑐𝑜𝑠𝜃
 
with K being a constant set to 0.89, λ denoting the wavelength of the X-ray radiation, 
FWHM corresponding to the full width at half maximum for the diffraction peaks and 
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𝜃beingthe diffraction angle. The calculated crystallite size of CMC-F-coated barium 
sulfate microparticles was around 19 nm. By evaluating the calculated crystallite size 
and particle size by scanning electron microscopy, the individual microparticles were 
polycrystalline. A long-term ultrasonication did not result in the disintegration of 
synthesized CMC-F-coated BaSO4 microparticles. 
 
Figure 43: Representative X-ray powder diffractogram of CMC-F-coated BaSO4 
microparticles. The red bars correspond to the orthorhombic barite phase. 
For quantification of the polymer content in CMC-F-coated BaSO4 microparticles, a 
thermogravimetric analysis was performed (Figure 44). Prior to the measurement, the 
dispersion of barium sulfate microparticles was dried in air. The experiments were 
carried out in a dynamic oxygen atmosphere at a heating rate of 2 K min-1 in alumina 
crucibles. The sample was heated to 1000 °C. In this temperature interval, only the 
organic part was effected, because a decomposition of barium sulfate starts only at 
1422 K.167 The polymer content of CMC-F-coated BaSO4 microparticles was about 5%. 
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Figure 44: Thermogravimetric analysis of CMC-F-coated BaSO4 microparticles after 
the sample was dried on air. 
As the synthesized CMC-F-coated barium sulfate microparticles were expected to be 
fluorescent due to the functionalization by carboxymethylcellulose conjugated with 6-
aminofluorescein, fluorescence spectroscopy was performed. 6-Aminofluorescein is a 
fluorophore that is commonly used in microscopy as a marker for numerous 
applications. Figure 45 shows the emission spectrum of functionalized barium sulfate 
microparticles. The emission spectrum was characteristic for 6-aminofluorescein for an 
excitation wavelength 490 nm. 
Results and discussions 
 
 
103 
 
 
 
Figure 45: Fluorescence spectrum of CMC-F-coated BaSO4 microparticles; excitation 
wavelength 490 nm. 
Figure 46 shows fluorescently-labelled BaSO4 microparticles. The image was 
processed by providing an overlay of light and fluorescence microscopy; the excitation 
wavelength was 490 nm. Before imaging, the particles were dried on a glass slip. The 
functionalized microparticles were shown in green. 
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Figure 46: Fluorescently labelled BaSO4 microparticles are shown in green. The image 
is an overlay of light and fluorescence microscopy; excitation wavelength 490 nm. 
The in situ observation of the colloidal particle stability is shown in Figure 47. All 
samples were well dispersable in cell culture medium. The colloidal stability of particles 
was determined by dynamic light scattering. The average particle size was determined 
over time. Due to their size, barium sulfate microparticles sedimented over a few hours 
of incubation in cell culture media supplemented with serum. However, after gentle 
shaking, the particles were easily dispersible again. No agglomerates were observed. 
The sedimentation and aggregation of a particulate system can be a crucial point in 
biological tests in vitro, while the bioavailability of the sample may vary for different cell 
lines (e.g., adherent or suspension cell cultures).168 
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Figure 47: Colloidal stability of synthetic CMC-F-coated barium sulfate microparticles 
in DMEM + 10% FCS medium at 37 °C under sterile condition. 
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5.4.2 Characterization of barium sulfate sub-microparticles 
BaSO4 sub-microparticles were synthesized by the precipitation of Na2SO4 and 
Ba(OH)2. The feeding of a precursor was performed by a peristaltic pump. 
Carboxymethylcellulose conjugated with 6-aminofluorescein (CMC-F) was used as a 
capping agent. Before analysis, the dispersion was purified by ultracentrifugation and 
then redispersed in pure water. In this way, CMC-F excess and by-products were 
removed. The samples were stored at 4 °C. An important variation in barium sulfate 
microparticle and sub-microparticle synthesis was the implementation of a Y-
connector. This mixing procedure is often called impinging streams.169-171 A perfect 
mixing can be realized within an extremely short time.172 Using this advantage, 
inorganic submicron materials could be synthesized. The local supersaturation of the 
reaction system was improved which resulted in a particle size reduction. These 
statements were proved by the physico-chemical characterization of the synthesized 
sub-microparticles.  
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Figure 48: Particle size distribution of CMC-F-coated BaSO4 sub-microparticles as 
measured by dynamic light scattering. 
The hydrodynamic diameter of barium sulfate sub-microparticles was measured by 
dynamic light scattering. Figure 48 shows the particle size distribution in water. The 
mean particle diameter was about 420 nm. The polydispersity index (PDI) was 0.181. 
The particles were negatively charged with a zeta potential of -26 mV.  
Morphological studies were performed on a dried suspension of purified CMC-F-
coated barium sulfate sub-microparticles by scanning electron microscopy. Figure 49 
shows typical micrographs for BaSO4 powders synthesized by impinging streams. The 
formed objects possessed a regular elliptical morphology. 
  
Figure 49: Scanning electron microscopy images of CMC-F-coated BaSO4 sub-
microparticles. 
The particle size distribution of dried samples was estimated by measuring individual 
particles. These results were plotted as a histogram. Figure 50 shows a monomodal 
particle size distribution with a mean particle diameter of 270 nm. A possible minor 
agglomeration could be one reason for the observed difference in size distribution by 
dynamic light scattering and electron microscopy. While the differential scattering 
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cross-sections are proportional to the 6th power of particle size, distributions by 
intensity of non-ideal disperse dispersions generally give larger particle diameters. 
 
Figure 50: Particle size distribution of CMC-F-coated BaSO4 sub-microparticles as 
measured by scanning electron microscopy. 
Elemental analysis was performed by energy-dispersive X-ray spectroscopy. Figure 
51 shows a representative spectrum for CMC-F-coated BaSO4 sub-microparticles. The 
results showed the presence of barium, sulfur, and oxygen. The peak of silicon resulted 
from the substrate, and the carbon peak is due to carboxymethylcellulose used as a 
capping agent.  
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Figure 51: Energy-dispersive X-ray spectrum of CMC-F-coated BaSO4 sub-
microparticles. 
For the quantification of organic matrix content in CMC-F-coated BaSO4 sub-
microparticles, thermogravimetric analysis was performed (Figure 52). Prior to 
measurement, the dispersion of barium sulfate sub-microparticles was dried on air. 
The experiments were carried out in a dynamic oxygen atmosphere at a heating rate 
of 2 K min-1 in alumina crucibles. During thermogravimetric examination, the sample 
was heated up to 1000 °C. The polymer content of CMC-F-coated BaSO4 sub-
microparticles was about 3%. 
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Figure 52: Thermogravimetric analysis of CMC-F-coated BaSO4 sub-microparticles 
after sample was dried on air. 
For the identification and characterization of crystalline solids, X-ray powder diffraction 
was used. Figure 53 shows a representative X-ray diffractogram of CMC-F-coated 
barium sulfate sub-microparticles. The measurements were performed on dried 
purified powders. All of the peaks can be readily indexed to a pure orthorhombic 
crystalline phase of BaSO4 (PDF No. 00-24-1035). The crystallite size was estimated 
with the Scherrer equation and found to be around 124 nm. However, the particle size 
distribution by scanning electron microscopy gave a mean particle diameter of 270±65 
nm.  
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Figure 53: Representative X-ray powder diffractogram of CMC-F-coated BaSO4 sub-
microparticles. The red bars correspond to the orthorhombic barite phase. 
The in situ observation of particle stability is shown in Figure 54. All samples were well 
dispersable in DMEM medium supplemented with 10% fetal calf serum at 37 °C to 
mimic cell culture experiments. The colloidal stability of particles was determined by 
dynamic light scattering. The average particle size was measured over time. The 
results were plotted as a z-average against the time of incubation (Figure 54). Barium 
sulfate sub-microparticles showed no significant difference in aggregation behavior 
during incubation in cell culture media with serum under sterile conditions over 10 h. 
No agglomerates were observed. Such a performance indicates a sufficient 
bioavailability of particulate system to cell culture suspensions in in vitro investigations.  
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Figure 54: Colloidal stability of synthetic CMC-F-coated barium sulfate sub-
microparticles in DMEM + 10% FCS medium at 37 °C under sterile condition. 
5.4.3 Characterization of barium sulfate nanoparticles 
Fluorescent barium sulfate nanoparticles were synthesized by precipitation from 
solutions of barium chloride and sodium sulfate in the presence of 
carboxymethylcellulose conjugated with 6-aminofluorescein. Many different 
approaches have been employed in the manufacture of well-dispersed BaSO4 
nanoparticles.169, 173-186 In the current report, the BaSO4 nanoparticles were 
synthesized by co-solvent precipitation in the presence of the polymer as a suitable 
modifying agent.180 Sodium sulfate was premixed with ethanol. Barium chloride was 
also premixed with carboxymethylcellulose conjugated with 6-aminofluorescein. The 
feeding procedure was performed by pumping sulfate-containing precursor into 
barium-containing solution. The feeding rate was around 4 µL s-1. The particles were 
collected by ultracentrifugation, redispersed in pure water and collected again by 
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ultracentrifugation. The barium sulfate nanoparticles were then redispersed in water 
by ultrasonication. In this way, polymer excess, barium excess and by-products were 
removed.  
Precipitation is a common procedure for the production of particles of different size 
distributions, morphologies, and other properties.187-190 The product properties are 
affected by various interconnected parameters like mixing, nucleation, growth, and 
processes such as agglomeration, aggregation, or ripening.186, 190-196 In our case, the 
use of a Y-connector reduced the particle size from micrometers down to ca. 300 nm. 
A further reduction of nucleation time did not have an effect. In this study, BaSO4 
nanoparticles were prepared by co-solvent precipitation in the presence of 
carboxymethylcellulose as suitable functionalizing agent. The previously described 
procedure was modified by pre-mixing of BaCl2 with carboxymethylcellulose. By such 
treatment of BaCl2 with carboxymethylcellulose, an electrostatic interaction of 
positively charged barium ions and negatively charged carboxymethylcellulose 
polymer chains may occur. This led to a decrease in freely available barium cations in 
the solution. Together with a slow feeding rate of sulfate ions, it results in nanosized 
particles. Moreover, the steric interference of carboxymethylcellulose on the surface of 
BaSO4 nanoparticles reduced the particle-particle interactions and limited the growth 
of larger agglomerates. 
The hydrodynamic diameter of barium sulfate nanoparticles was measured by dynamic 
light scattering. Figure 55 shows the particle size distribution in water. The mean 
particle diameter was about 70 nm. A secondary peak was also detected, possibly as 
a redispersion artifact. The polydispersity index (PDI) was 0.253. The particles were 
negatively charged with a measured zeta potential of -23 mV. It showed the 
electrosteric nature of colloid stability.  
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Figure 55: Particle size distribution of CMC-F-coated BaSO4 nanoparticles as 
measured by dynamic light scattering. 
Scanning electron micrographs for barium sulfate (Figure 56) showed regular spherical 
nanoparticles. The individual spherical particles were analyzed, and the results are 
shown as histogram. Figure 57 shows a narrow monomodal particle size distribution 
of the dried sample. The mean particle size assessed by scanning electron microscopy 
was 40±7 nm. The particle diameter measured by dynamic light scattering and electron 
microscopy was different, while the slight agglomeration of particles in solution 
occurred after double ultracentrifugation. 
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Figure 56: Scanning electron microscopy images of CMC-F-coated BaSO4 
nanoparticles. 
 
Figure 57: Particle size distribution of CMC-F-coated BaSO4 nanoparticles as 
measured by scanning electron microscopy. 
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Energy-dispersive X-ray spectroscopy detected signals of barium, sulfur and oxygen. 
Typical spectrum is shown in Figure 58. The peak of silicon is due to the substrate. 
The carbon peak was corresponded to the carboxymethylcellulose polymer.  
 
Figure 58: Energy-dispersive X-ray spectrum of CMC-F-coated BaSO4 nanoparticles. 
For quantification of the organic matrix content in CMC-F-coated BaSO4 nanoparticles, 
thermogravimetric analysis was performed (Figure 59). Prior to measurement, the 
dispersion of barium sulfate nanoparticles was dried on air. The experiments were 
carried out in a dynamic oxygen atmosphere at a heating rate of 2 K min-1 in alumina 
crucibles. During thermogravimetric examination, the sample was heated to 1000 °C. 
The decomposition of barium sulfate starts only at 1422 K.167 The polymer content of 
CMC-F-coated BaSO4 nanoparticles was about 15%.  
Results and discussions 
 
 
117 
 
 
 
Figure 59: Thermogravimetric analysis of CMC-F-coated BaSO4 nanoparticles in a 
dynamic oxygen atmosphere. 
To prove the crystalline nature of the produced particles and identify the 
crystallographic phase, X-ray powder diffraction was performed. Figure 60 depicts the 
representative X-ray diffractogram of CMC-F-coated barium sulfate nanoparticles. The 
measurements were performed on dried purified powders. All of the peaks were readily 
indexed to a pure orthorhombic crystalline phase of BaSO4, which was in good 
agreement with the literature (PDF No. 00-24-1035). Characteristic broadening of 
diffraction peaks revealed the formation of nanocrystalline precipitate. The crystallite 
size was estimated with the Scherrer equation. It was found to be around 35 nm. The 
mean particle size measured by scanning electron microscopy agreed well with the 
determined crystallite size. 
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Figure 60: Representative X-ray powder diffractogram of CMC-F-coated BaSO4 
nanoparticles. The red bars correspond to the orthorhombic barite phase. 
Figure 61 shows fluorescently-labelled BaSO4 nanoparticles. The left image was 
processed by fluorescence microscopy and the right one by light microscopy. An 
excitation wavelength was 490 nm. Before imaging, the particles were dried on a cover 
glass. The functionalized nanoparticles are shown in green. No strong agglomeration 
of functionalized BaSO4 nanoparticles was observed after double ultracentrifugation. 
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Figure 61: Fluorescently-labelled BaSO4 nanoparticles show up in green. Left: 
fluorescence microscopy; right: light microscopy; excitation wavelength is 490 nm. 
The colloidal stability of produced dispersions was tested in DMEM + 10% FCS (Figure 
62). DMEM is a typically used cell medium for the culturing of eukaryotic cells. The 
experiments were performed under sterile conditions at 37 °C. The evaluation was 
performed as a control of the hydrodynamic diameter of suspended fluorescently-
labelled BaSO4 nanoparticles over time. The graph was plotted as z-average vs. time. 
It is interesting that the initial size of particles in biological medium was not the same 
as in pure water. Over 10 h, barium sulfate nanoparticles showed no significant 
difference in aggregation behavior during incubation in cell culture media with serum 
under sterile conditions. 
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Figure 62: Colloidal stability of synthetic CMC-F-coated barium sulfate nanoparticles 
in DMEM + 10% FCS medium at 37 °C under sterile condition. 
In conclusion, a controlled synthesis of fluorescently-labeled BaSO4 nanoparticles, 
sub-microparticles and microparticles with a narrow size distribution was achieved. 
The resultant particles were uniform in shape, chemical composition, and surface 
modification. All particles were colloidally dispersable in cell culture medium with 
serum.  
Table 7 summarizes the physico-chemical characterization for the synthesized barium 
sulfate particles. The hydrodynamic diameter of particles was studied by dynamic light 
scattering. All particles were negatively charged due to functionalization with 
carboxymethylcellulose. Identity and crystallinity of the substances were confirmed by 
X-ray powder diffraction. All materials crystallized in orthorhombic barite phase. The 
size of the crystallites was calculated with the Scherrer equation. By evaluation of the 
calculated crystallite size and particle size by scanning electron microscopy, it was 
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notable that microparticles were polycrystalline, whereas nanoparticles presumably 
consisted of a single domain. The content of the organic matrix was computed from 
the results of thermogravimetric analysis. The highest polymer amount was found in 
the case of nanoparticles. Sub-micro and microparticles possessed a comparable 
quantity of adsorbed carboxymethylcellulose. Size and morphology of the dried 
dispersion were determined by scanning electron microscopy. The particle number per 
g was derived by dividing 1 g by the mass of one particle. The particle mass results 
from the following formula: 
𝑚𝑃𝑎𝑟𝑡𝑖𝑐𝑙𝑒 =
4
3
𝜋𝑟3𝜌 
where r is the radius of particle obtained from results of electron microscopy and ρ is 
the density of barium sulfate. The specific surface area was calculated with formula: 
𝑆 = 4𝜋𝑟2𝑁𝑃𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 𝑝𝑒𝑟 1 𝑔 
The calculated specific surface area for synthesized nanoparticles is in the range of 
the typical values from literature.63 In the last column, a typical sample under UV light 
irradiation (λ=400 nm) after ultrasonication in pure water is shown.  
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Table 7: Summary of the characterization of synthesized barium sulfate particles. 
Barium sulfate 
Mean 
particle 
diameter by 
DLS / nm 
PDI 
Z-Potential / 
mV 
Mean 
particle 
diameter 
by SEM / 
nm 
Crystallite 
size by XRD / 
nm 
Amount of 
organic 
matrix by 
TG / % 
Crystalline 
phase by XRD 
Particle 
number 
(calculated) 
per g 
Specific 
surfaces 
area 
(calculated) 
/ m2g-1 
Typical 
sample 
imaged 
under UV 
light 
irradiation 
(λ=400 nm) 
Nanoparticles 70±15 0.253 -23±3 40±7 35 15 
Barite, 
orthorhombic 
3.9·1015 25.3 
 
Sub-
microparticles 
420±196 0.181 -26±6 270±65 124 3 
Barite, 
orthorhombic 
2.2·1013 4.8 
Microparticles 1480±260 0.079 -35±6 1300±210 19 5 
Barite, 
orthorhombic 
1.3·1011 0.8 
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5.4.4 Cellular uptake of fluorescent barium sulfate particles 
Fluorescently-labeled barium sulfate nano-, sub-micro- and microparticles were 
incubated with NR8383 macrophages. The NR8383 cell line provides a homogeneous 
source of highly responsive alveolar macrophages which can be used in vitro to study 
macrophage related activities. The presence of the particles was measured by 
confocal laser scanning microscopy. The cells were exposed to 50 µg mL-1 BaSO4 
particles for 24 h under cell culture conditions. After this incubation, the cells were 
labeled with specific cell organelle fluorescent probes. As a marker for late endosomes 
and lysosomes, the cells were incubated with 50 nM Lyso Tracker Red DND 99 in pure 
RPMI 1640 for 30 min at 37 °C. For labelling of the cell nucleus, the cells were 
incubated with 162 µM Hoechst33342 in pure RPMI 1640 for 5 min at 37 °C. After three 
rinses in RPMI 1640, the cells were mounted on glass chamber slides. Images were 
taken using a 40x oil immersion objective in a laser scanning microscope.  
Figure 63 shows the cellular uptake of labeled barium sulfate nano-, sub-micro- and 
microparticles by NR8383 alveolar macrophages. The cell nucleus was shown in blue, 
late endosomes and lysosomes in red and particles in green. The upper images are 
combinations of bright field microscopy and fluorescence microscopy of the cell 
nucleus. The imaging area was selected to be representative for adherent cell 
population. As control, cells incubated in particle-free medium were used. Due to the 
fluorescence staining of cell organelles the presence of barium sulfate nano-, sub-
micro-, and microparticles in lysosomes and late endosomes was confirmed. 
 
Results and discussions 
 
 
124 
 
 
 
Figure 63: Cellular uptake of fluorescently-labeled barium sulfate particles by NR8383 macrophages. The scale bar is 20 μm.
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Figure 64: Cellular uptake of fluorescently-labeled barium sulfate particles by NR8383 
macrophages as analyzed by flow cytometry. Quantitative data are expressed as the 
mean±SD (N = 3 independent experiments), given as the percent of the control (cells 
cultured without particles). The asterisk (*) indicates significant differences compared 
to the control (*p<0.05). A typical measurement run of flow cytometry is shown for 
barium sulfate microparticles in the lower right corner.  
Figure 64 shows the quantitative interpretation of cellular uptake of labeled barium 
sulfate nano-, sub-micro- and microparticles by NR8383 alveolar macrophages, as 
measured by flow cytometry. Flow cytometry is normally used in biotechnology for cell 
counting and sorting.60, 68, 74, 197, 198 As shown in a typical run, the increase of 
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fluorescently-labeled particles in the cell resulted in a higher fluorescence signal (right 
shift). NR8383 macrophages are mixed culture.199-202 Taking into account this fact, the 
suspended cell fractions as well as adherent cell fractions were analyzed. Figure 64 
shows the results plotted as fluorescent intensity with concentration of added labeled 
barium sulfate particles. The data suggest that an increase of the mean fluorescence 
intensity is concentration-dependent. A significant difference occurred in the case of 
barium sulfate microparticles for suspended and adherent cell fractions. It can be 
explained by the sedimentation of particles over time. This was confirmed by stability 
studies of dispersed particles in biological medium by dynamic light scattering.203 
However, an accurate quantitative study of particle uptake should involve a cytometer 
calibration. Flow cytometer sensitivity is often expressed in the form of molecules of 
equivalent soluble fluorochrome (MESF).204 Moreover, the fluorophore content of the 
nano-, sub-micro-, and microparticles should be measured in order to get quantitative 
information about, how many particles were taken up by an individual cell. 
5.4.5 Inflammatory potential of fluorescently-labeled barium sulfate nano-, sub-
micro-, and microparticles 
Particle inhalation can cause severe inflammatory lung diseases such as chronic 
obstructive pulmonary disease (COPD) as well as lung fibrosis and even tumors. 
These diseases are believed to be a consequence of chronic lung inflammation which 
can occur at high continuous particle exposure.205-213 Particle-induced inflammation of 
the lung is initiated by the recruitment of macrophages and neutrophilic 
granulocytes.168  
Accumulation of neutrophils in the lung is a hallmark of inflammatory reactions towards 
a broad spectrum of particles occurring at different workplaces and in the 
environment.210, 214-217 Westphal et al. described a model which displays the attraction 
of neutrophils in response to particle challenge using permanent cell lines.  
An inflammatory potential of nano-, sub-micro-, and microparticles was evaluated by 
particle-induced cell migration assay (PICMA).168 NR8383 rat alveolar macrophages 
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were challenged with up to 200 µg mL-1 BaSO4 in the form of nano-, sub-micro- and 
microparticles. The cell supernatants were used to induce cell migration of trans-retinal 
differentiated human leukemia cells (dHL-60 cells). Figure 65 shows the migration of 
dHL- 60 cells in response to culture supernatants which were yielded after a challenge 
of NR8383 macrophages with nano-, sub-micro- and microparticles. 
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Figure 65: Migration of dHL-60 cells in response culture supernatants which were obtained following the challenge of NR8383 alveolar 
macrophages with nano-, sub-micro-, and microparticles. No chemotactic effect wasobserved dHL-60 cells. The released chemokines 
concentration did not trigger the migration of neutrophils.  
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The data reported in Figure 65 showed no chemotactic effect on dHL-60 cells. This 
means that chemokines were either not released at all or that they were released at a 
concentration which was not sufficient to trigger the migration of neutrophils. In this 
case, a migration of neutrophils should give a measurement of the inflammatory 
potential of the tested materials, since the accumulation of neutrophils was a hallmark 
of lung inflammation. No dose-dependency of particle-induced chemotaxis of dHL-60 
cells in response to cell supernatants of particle challenged NR8383 macrophages 
could be shown. BaSO4 was repeatedly shown to be not or only very weakly 
inflammatory in vivo.218, 219 In agreement with these data weak - if any - cell migration 
was observed following a challenge with BaSO4 nano-, sub-micro-, and microparticles. 
Moreover, no size effect of barium sulfate was observed. 
The results of the present study demonstrated that barium sulfate nano-, sub-micro- 
and microparticles were fabricated and characterized extensively. Neither dose nor 
size dependency were shown for the particle-induced chemotaxis. These facts allow 
to use barium sulfate as a model compound for inert nanoparticle to identify factors 
which contribute to particle-induced inflammation. 
 
.
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6 Summary 
This work comprises the synthesis procedures of toxicologically relevant particles, and 
their behavior in complex biological media in terms of stability and dissolution, with 
specific biological responses to the synthesized materials. Two toxicologically relevant 
particulate systems were studied. As a model of a biologically active material, silver 
compounds, especially silver nanoparticles, were investigated. In contrast, barium 
sulfate was examined as a bioinert system. 
The formation of silver nanoparticles during the reduction with glucose in the presence 
of poly(vinylpyrrolidone) as a capping agent was followed for more than 3000 min. It 
was shown that spherical silver nanoparticles were formed first, but in later stages, an 
increasing fraction of nano-triangles and also a few nanorods developed. By electron 
microscopy, the growth of spherical and trigonal nanoparticles with time was 
described. From X-ray powder diffractometry, it was concluded that the domain size in 
the spherical nanoparticles increased proportionally to the particle diameter and was 
always about ¼ of the diameter, indicating that twinned seeds were formed very early 
in the process and then simply grew by extending their size. The lattice constant of the 
nanoparticles was systematically increased in comparison to microcrystalline silver, 
but did not change as a function of particle diameter.  
The behavior of silver ions was investigated in biologically relevant concentrations in 
different media, from physiological salt solution over phosphate-buffered saline 
solution to protein-containing cell culture media. The results showed that silver ions 
that were initially present were bound as silver chloride due to the presence of chloride. 
Only in the absence of chloride, glucose was able to reduce Ag+ to Ag0. The 
precipitation of silver phosphate was never observed in any case. It was concluded 
that the predominant silver species in biological media is dispersed nanoscopic silver 
chloride, surrounded by a protein corona which prevents the growth of crystals and 
leads to colloidal stabilization. Using bacteria (S. aureus) and cell culture experiments 
(human mesenchymal stem cells; T-cells; monocytes), it was possible to show that a 
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toxic effect occurred at the same silver concentration of ionic silver and synthetically 
prepared silver chloride nanoparticles. Furthermore, the dissolution of silver 
nanoparticles and the solubility products of silver chloride and silver nitrate were 
quantified in protein-containing cell culture media.  
Barium sulfate micro-, sub-micro-, and nanoparticles were synthesized for evaluation 
of inflammatory potential. The synthesis of fluorescent labeled BaSO4 particles with a 
narrow size distribution was achieved. The resultant powders were uniform in form, 
chemical composition and surface modification by the fluorescent dye. All of the 
particles were colloidally dispersed in cell culture medium with serum. From the cellular 
uptake studies on rat alveolar macrophages, it was concluded that a significant 
difference occurred in the case of barium sulfate microparticles for suspended and 
adherent cell fractions. This was explained by the sedimentation of synthesized 
particles over time, and confirmed by stability studies of dispersed particles in biological 
medium by dynamic light scattering. However, in a particle-induced cell migration 
assay for evaluation of the inflammation potential of the system, no dose- and size-
dependency was found.  
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8 Appendix 
8.1 List of abbreviations 
AAS Atomic absorption spectroscopy 
CMC-F Carboxymethylcellulose conjugated with 6-aminofluorescein 
DLS Dynamic light scattering 
DLVO  Derjaguin, Landau, Verwey, Overbeek 
DMEM Dulbecco's modified Eagle's medium 
DMEM + 10% FCS Dulbecco's modified Eagle's medium supplemented with 10% 
fetal calf serum 
EDTA Ethylenediaminetetraacetate 
EDX Energy-dispersive X-ray spectroscopy 
FACS Fluorescence-activated cell sorting 
FCS Fetal calf serum 
FWHM Full width at half maximum 
HeLa Henrietta Lacks 
Appendix 
 
 
144 
 
 
hMSCs Human mesenchymal stem cells 
JCPDS  Joint Committee on Powder Diffraction Standards 
LB Lysogeny broth 
MBC Minimum bactericidal concentration 
MIC Minimum inhibitory concentration 
NR8383 Rat alveolar macrophages 
NTA Nanoparticle tracking Analysis 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate-buffered saline 
PDI Polydispersity index 
PEI Poly(ethyleneimine) 
PVP Poly(vinylpyrrolidone) 
ROS Reactive oxygen species 
RPMI Roswell Park Memorial Institute 
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S. aureus Staphylococcus aureus 
SEM Scanning electron microscopy 
TEM Transmission electron microscopy 
Uv/Vis Ultraviolett / Visible 
XRD X-ray diffraction 
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8.3 Posters and presentations 
Microstructure physics and alloy design department, Max-Planck-Institut für 
Eisenforschung, Düsseldorf, Germany, 10.11.2015, K. Loza, "Nanostructure of wet-
chemically prepared, polymer-stabilized silver-gold nanoalloys (6 nm) over the entire 
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Chemistry Department, Panjab University, Chandigarh, India, 15.07.2015, K. Loza, 
"Inorganic nanoparticles for biomedical application" (oral presentation) 
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6th Late Summer Workshop "Micropollutants in the water cycle" Schloss Maurach, Lake 
Constance, Germany, 29.09-2.10.2013, K. Loza, J. Diendorf, C. Greulich, M. Köller, 
M. Epple, "On the behavior of silver nanoparticles in complex media" (poster) 
Jahrestagung der Deutschen Gesellschaft für Biomaterialien, Erlangen, Germany, 6.-
28.09.2013, C. Greulich, K. Loza, M. Epple, T. Schildhauer, M. Köller, "Subtoxic 
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